Special Article
Chronic Health Conditions in Adult Survivors of Childhood Cancer
N Engl J Med 2006; 355:1572-1582October 12, 2006
- Abstract
Background
Only a few small studies have assessed the long-term morbidity that follows the treatment of childhood cancer. We determined the incidence and severity of chronic health conditions in adult survivors.
Methods
The Childhood Cancer Survivor Study is a retrospective cohort study that tracks the health status of adults who received a diagnosis of childhood cancer between 1970 and 1986 and compares the results with those of siblings. We calculated the frequencies of chronic conditions in 10,397 survivors and 3034 siblings. A severity score (grades 1 through 4, ranging from mild to life-threatening or disabling) was assigned to each condition. Cox proportional-hazards models were used to estimate hazard ratios, reported as relative risks and 95% confidence intervals (CIs), for a chronic condition.
Results
Survivors and siblings had mean ages of 26.6 years (range, 18.0 to 48.0) and 29.2 years (range, 18.0 to 56.0), respectively, at the time of the study. Among 10,397 survivors, 62.3% had at least one chronic condition; 27.5% had a severe or life-threatening condition (grade 3 or 4). The adjusted relative risk of a chronic condition in a survivor, as compared with siblings, was 3.3 (95% CI, 3.0 to 3.5); for a severe or life-threatening condition, the risk was 8.2 (95% CI, 6.9 to 9.7). Among survivors, the cumulative incidence of a chronic health condition reached 73.4% (95% CI, 69.0 to 77.9) 30 years after the cancer diagnosis, with a cumulative incidence of 42.4% (95% CI, 33.7 to 51.2) for severe, disabling, or life-threatening conditions or death due to a chronic condition.
Conclusions
Survivors of childhood cancer have a high rate of illness owing to chronic health conditions.
Media in This Article
Figure 1
Cumulative Incidence of Chronic Health Conditions among 10,397 Adult Survivors of Pediatric Cancer, According to the Original Diagnosis and the Severity of the Later Condition.Table 1
Demographic Characteristics of Adult Survivors of Childhood Cancer and Siblings.Article Activity
- Article
As a result of advances in treatment, almost 80% of children and adolescents who receive a diagnosis of cancer become long-term survivors.1 In the United States, there are approximately 270,000 survivors of pediatric cancer, or about 1 of every 640 adults between the ages of 20 and 39 years.2 The large number of survivors has prompted studies of the long-term health consequences of treatments for childhood cancer.2-4 It is now clear that damage to the organ systems of children caused by chemotherapy and radiation therapy may not become clinically evident for many years.
To understand fully the health risks incurred by treatment of childhood cancer, it is important to measure three types of long-term outcomes: health status, mortality, and morbidity. Of these, the first two have been fairly well characterized.5,6 In a retrospective analysis of 20,227 5-year survivors of cancer, Mertens et al.5 found statistically significant excess rates of death from subsequent cancers (standardized mortality ratio [SMR], 19.4), from cardiac causes (SMR, 8.2), and from pulmonary causes (SMR, 9.2). In a study of 9535 adults who had survived childhood cancer, 44% reported having at least one domain of health status (general health, mental health, functional status, limitations in activity, cancer-related pain, and cancer-related fear or anxiety) that was moderately or severely affected.6
However, only a few small studies have assessed the long-term morbidity that follows the treatment of childhood cancer. Four studies, with a combined sample of 1330 survivors, reported an estimate of the prevalence of “late effects,” or chronic conditions that were possibly associated with cancer therapy.7-10 The small sample limited the ability of these studies to assess the risk of chronic conditions associated with a particular treatment. Moreover, there were no comparison groups to provide perspective, and the outcomes were reported for survivors who were relatively young and still involved in follow-up care. The Institute of Medicine report Childhood Cancer Survivorship: Improving Care and Quality of Life highlights the need for further research to characterize the health of long-term survivors of childhood cancer and to determine the prevalence and incidence of adverse health outcomes and chronic conditions after cancer therapy.2
The purpose of this study was to investigate the large and geographically diverse cohort that is followed in the Childhood Cancer Survivor Study (CCSS), with the goal of determining the prevalence, incidence, and severity of chronic health conditions in adult survivors of childhood cancer, and to determine the risk of chronic conditions in the survivors, as compared with their siblings. In addition, we sought to identify subpopulations of survivors at highest risk for severe, debilitating, or life-threatening chronic health conditions. In short, we sought to provide an estimate of the overall physical morbidity secondary to the type of cancer and cancer therapy.
Methods
Subjects
CCSS is a multi-institutional, retrospectively ascertained cohort of adults who have survived for at least 5 years after treatment for childhood cancer. Our study was restricted to participants who met the following criteria: a diagnosis of leukemia, central nervous system (CNS) tumor, Hodgkin's disease, non-Hodgkin's lymphoma, Wilms' (kidney) tumor, neuroblastoma, soft-tissue sarcoma, or bone tumor; a diagnosis and initial treatment at one of 26 collaborating CCSS institutions; a date of diagnosis between January 1, 1970, and December 31, 1986; an age of less than 21 years at diagnosis; and survival for at least 5 years after the date of diagnosis. The institutional review board at each participating center reviewed and approved the CCSS protocol and documents sent to participants. All study participants provided written informed consent for participation in the study and for the release of medical-record information. A detailed description of the study design and characteristics of the cohort was reported previously.11 The questionnaire that was administered to all participants at baseline and the treatment abstraction form are available at www.cancer.umn.edu/research/ltfu/ccssquestionnaires.html and in Section A of the Supplementary Appendix, available with the full text of this article at www.nejm.org.
Of the 20,720 survivors of childhood cancer in the cohort, 3017 (14.6%) were lost to follow-up after extensive efforts failed to locate them. Among the remaining 17,703 subjects, 14,372 (81.2%), including 10,397 who were 18 years of age or older at the time they were interviewed, completed the baseline questionnaire. To determine the potential for introducing bias into the studied cohort, we previously compared demographic and cancer-related characteristics among participants, nonparticipants, and those who were lost to follow-up. We found that these three groups were similar with regard to sex, the type of cancer, the age at diagnosis, the age at which they were asked to participate in the study (or for those lost to follow-up, the age at which the cohort was assembled), and the type of cancer treatment.11,12
To allow for comparisons with a population that had not been treated for cancer, we asked a random sample of participating survivors to identify a nearest-age living sibling. Of 4782 eligible siblings, 3846 (80.4%) participated; of these, 3034 were 18 years of age or older.
Cancer Treatment Information
We obtained information on the original cancer diagnosis from the treating institution. For the 12,752 participants who returned a signed medical release, the information on cancer therapy included their initial treatment, treatment for any relapse, and preparatory regimens for bone marrow transplantation (if applicable). Data regarding exposure to 42 chemotherapeutic agents (either yes or no) were abstracted from the medical record; cumulative doses were abstracted for 22 of these agents. Data were also obtained on surgical procedures performed for cancer treatment at any time from the date of diagnosis onward, as well as on the site of the tumor and on fields and doses of radiation therapy. (See Sections B through D in the Supplementary Appendix for details concerning these treatments.)
Health Condition Outcomes
At enrollment, survivors and siblings completed a 289-item questionnaire that included questions regarding their physical health conditions, including their age at the onset of the condition. All second cancers that were ascertained from a participant or a physician's report were verified by a review of pathology reports performed by Dr. S. Hammond at the CCSS Pathology Center in Columbus, OH.
To determine the severity of the conditions, scoring was based on the Common Terminology Criteria for Adverse Events (version 3), a scoring system developed through the National Cancer Institute by a multidisciplinary group and intended for use in scoring both acute and chronic conditions in patients with cancer and survivors of all ages.13 The system grades conditions as mild (grade 1), moderate (grade 2), severe (grade 3), life-threatening or disabling (grade 4), or fatal (grade 5). For our study, a total of 137 health conditions were scored. As specified in the scoring system, when a particular condition was not listed, it was entered in the “Other, specify” category according to the organ system affected. If there was not enough information to distinguish between grades, the lower score was selected. Adverse psychosocial outcomes, including depression and anxiety disorder, were not included in this analysis. Before data analysis, all the authors agreed on all scores.
The same scoring system was used to grade the conditions of siblings. However, because the design of the study included only living siblings at the time of study entry, there were no siblings with a grade 5 (fatal) condition.
Statistical Analysis
We determined the prevalence of chronic conditions among survivors and siblings. Three primary outcomes were assessed: any condition (grades 1 through 4), severe or life-threatening conditions (grade 3 or 4), and multiple conditions (≥2). For participants who had more than one condition, the maximum grade was used. For deceased survivors, the maximum grade of a condition reported before death was used for comparisons with siblings. For example, if a survivor died of a myocardial infarction, the grade for myocardial infarction (grade 4) was used rather than the grade for a fatal condition (grade 5). Hazard ratios were estimated with the use of Cox regression and are reported as relative risks with 95% confidence intervals (CIs). Comparisons between survivors and siblings were adjusted for the age at enrollment, sex, and race or ethnic group. The analysis accounted for within-family correlations with the use of sandwich standard-error estimates.14 The risk associated with treatment with radiation and chemotherapy agents was analyzed with the use of specific classes of chemotherapeutic agents and according to specific anatomical sites of radiation therapy.
Cumulative incidence rates for each of the primary outcomes were calculated for the survivors, with death treated as a competing risk according to the method described by Gooley et al.15 Cumulative incidence rates for siblings were not calculated because the design of the study included only living siblings at the time of study entry.
The starting point for both survivors and siblings was 5 years after the date of diagnosis of cancer. If the date of onset of an irreversible condition, such as blindness, occurred within the first 5 years after the date of diagnosis, the condition was considered to be present 5 years after diagnosis; for the purposes of analysis, the onset date was shifted forward to that time point. Data were analyzed with SAS software, version 9.0 (SAS Institute).
Results
Comparisons of Survivors with Siblings
Table 1Table 1
Demographic Characteristics of Adult Survivors of Childhood Cancer and Siblings. shows the characteristics of the survivor and sibling cohorts. The mean age of the survivors was 26.6 years (range, 18.0 to 48.0), and the mean interval from the date of diagnosis of cancer to the date of completion of the questionnaire was 17.5 years (range, 6.0 to 31.0). Of the survivors, 46.2% were women and 16.0% were members of minority groups. The mean age of the siblings was 29.2 years (range, 18.0 to 56.0); 52.9% were women, and 8.1% were members of minority groups (Table 1 lists relevant P values).Among the survivors, 62.3% reported having at least one chronic health condition, with 27.5% reporting a grade 3 (severe) or grade 4 (life-threatening or disabling) condition (Table 2Table 2
Cancer Survivors and Siblings with a Chronic Health Condition, According to the Severity Score., and Section E of the Supplementary Appendix, which lists the 137 conditions reported in the health questionnaire). Among survivors, 37.6% reported having at least two conditions listed in Supplementary Appendix E, and 23.8% reported having three or more conditions. In contrast, among siblings, 36.8% reported having a chronic health condition, of which 5.2% reported having a condition of grade 3 or 4; 13.1% reported having at least two conditions, and 5.4% reported having three or more conditions. The relative risks of 10 selected conditions of grade 3 or 4 for survivors as compared with siblings are provided in Table 3Table 3
Relative Risk of Selected Severe (Grade 3) or Life-Threatening or Disabling (Grade 4) Health Conditions among Cancer Survivors, as Compared with Siblings..After adjustment for the age at completion of the questionnaire or death, sex, and race or ethnic group, survivors were 3.3 times as likely as their siblings to have a chronic health condition of any grade (95% CI, 3.0 to 3.5) (Table 4Table 4
Relative Risk of a Chronic Health Condition among Cancer Survivors, According to the Type of Tumor and Treatment, as Compared with Siblings.). The relative risk of a survivor having any condition of grade 3 or 4, as compared with siblings, was 8.2 (95% CI, 6.9 to 9.7). Survivors were 4.9 times as likely to have two or more chronic health conditions (95% CI, 4.4 to 5.5). Groups at highest risk for having a condition of grade 3 or 4 were survivors of bone tumors (relative risk, 38.9; 95% CI, 31.2 to 48.5), CNS tumors (relative risk, 12.6; 95% CI, 10.3 to 15.5), and Hodgkin's disease (relative risk, 10.2; 95% CI, 8.3 to 12.5). All cancer groups were significantly more likely to have any condition, a condition of grade 3 or 4, and two or more conditions, as compared with siblings (P<0.001 for all comparisons).The relative risks associated with various combinations of therapy for survivors, as compared with siblings, are listed in Table 4. (Sections B, C, and D of the Supplementary Appendix list the types of chemotherapy, surgery, and radiotherapy received by the survivors.) Exposure to one of five specific combinations was associated with a risk of having a condition of grade 3 or 4 that was at least 10 times the expected risk: chest radiation plus bleomycin (relative risk, 13.6; 95% CI, 9.8 to 18.7), chest radiation plus an anthracycline (relative risk, 13.0; 95% CI, 10.4 to 16.3), chest radiation plus abdominal or pelvic irradiation (relative risk, 10.9; 95% CI, 8.9 to 13.2), an anthracycline plus an alkylating agent (relative risk, 10.9; 95% CI, 9.0 to 13.1), and abdominal or pelvic irradiation plus an alkylating agent (relative risk, 10.0; 95% CI, 8.2 to 12.1). An increase in the cumulative dose of an alkylating agent was associated with an increased risk of any condition or multiple conditions. In a similar way, an increase in the cumulative dose of an alkylating agent in combination with any type of irradiation was associated with an increased relative risk. In contrast, an increase in the cumulative dose of an anthracycline was not associated with an increased risk of any condition (grades 1 through 4) that we listed.
Comparisons among Survivors
The sex and age of the survivor at the time of the diagnosis of cancer modified the risk of having a condition of grade 3, 4, or 5. As compared with male survivors and with adjustment for the type of cancer, age at the time of the study, and race or ethnic group, female survivors were 1.5 times as likely to have any condition of grade 3 or higher (95% CI, 1.3 to 1.6). Female survivors were also more likely than male survivors to have any condition (grades 1 through 5; relative risk, 1.4; 95% CI, 1.3 to 1.5) and to have multiple conditions (relative risk, 1.5; 95% CI, 1.4 to 1.7). The age of the survivor at diagnosis also independently modified the risk when the analysis was adjusted for age at the time of the study, sex, and race or ethnic group. For each cancer group, survivors who received the diagnosis at an older age were significantly more likely to report any condition, conditions of grades 3 through 5, or multiple conditions (P<0.001). The race or ethnic group of the survivor did not affect the likelihood of having a condition of grade 3 or higher. However, black non-Hispanic survivors were less likely than white non-Hispanic survivors to have any condition (grades 1 through 5; relative risk, 0.8; 95% CI, 0.6 to 0.9) or multiple conditions (relative risk, 0.7; 95% CI, 0.5 to 0.8) (data not shown).
Figure 1Figure 1
Cumulative Incidence of Chronic Health Conditions among 10,397 Adult Survivors of Pediatric Cancer, According to the Original Diagnosis and the Severity of the Later Condition. shows the cumulative incidence of chronic health conditions reported by survivors during the interval from the time of the diagnosis to the time of the study. The cumulative incidence of a chronic health condition was 66.8% 25 years after the diagnosis, with an estimated incidence of 73.4% (95% CI, 69.0 to 77.9) at 30 years. For conditions of grades 3 through 5 (severe, disabling, life-threatening, or fatal), the cumulative incidence 25 years after the diagnosis was 33.1%, with an estimated incidence of 42.4% (95% CI, 33.7 to 51.2) at 30 years. The cumulative incidence of multiple conditions (≥2) was 38.5% 25 years after diagnosis, with an estimated incidence of 39.2% (95% CI, 37.7 to 40.8) at 30 years.Discussion
Long-term survivors of pediatric cancer are more likely to have diminished health status and to die prematurely than are adults who never had childhood cancer, but only a few small studies have assessed the frequency and severity of chronic conditions in this population. In addition to small samples and selection bias, previous studies have been limited by their focus on the prevalence of health conditions that developed during a relatively short interval after the cancer diagnosis, thus limiting the assessment of whether the risk changes with time.7-10 Our study of more than 10,000 adult survivors of childhood cancer who were treated in the 1970s and 1980s shows that the risk of chronic health conditions is high, particularly for second cancers, cardiovascular disease, renal dysfunction, severe musculoskeletal problems, and endocrinopathies. Moreover, the incidence of chronic conditions, including these five groups of serious outcomes, increases over time and does not appear to plateau.
These findings underscore the necessity of continued follow-up of survivors of childhood cancer, with an emphasis on surveillance for second cancers (e.g., breast and colorectal cancer, melanoma, and nonmelanoma skin cancer), coronary artery disease, late-onset anthracycline-related cardiomyopathy, pulmonary fibrosis, and endocrinopathies (e.g., premature gonadal failure, thyroid disease, osteoporosis, and hypothalamic and pituitary dysfunction). Follow-up care of survivors should also include secondary and tertiary prevention (e.g., strategies to promote tobacco cessation or avoidance, physical activity, and proper weight management) and management of chronic disease.
As a group, cancer survivors were eight times as likely as their siblings to have severe or life-threatening chronic health conditions (e.g., myocardial infarction, congestive heart failure, premature gonadal failure, second cancers, and severe cognitive dysfunction). Three groups were at highest risk: survivors of bone tumors, CNS tumors, and Hodgkin's disease. In addition to being at increased risk for particular health conditions, survivors of these tumors were also more likely to have multiple conditions. For example, bone-tumor survivors with multiple conditions more frequently had severe musculoskeletal problems, congestive heart failure, and hearing loss. CNS-tumor survivors with multiple conditions were more likely to have cognitive dysfunction, seizure disorders, and various endocrinopathies. Hodgkin's disease survivors with multiple conditions were more likely to have cardiovascular disease (coronary artery disease, cerebrovascular accident, valvular heart disease, or cardiomyopathy), second cancers (particularly breast cancer in women), lung disease, and thyroid disorders.
In the 1970s, effective treatment for osteosarcoma of the limbs generally included amputation. Even with modern limb-sparing procedures, the life-altering musculoskeletal morbidity faced by bone-tumor survivors is clinically significant and will increase as weight-bearing joints age more rapidly, owing to asymmetric stress and altered function.16-18 Since bone-tumor survivors are the group most likely to have severe limitations in activity,18 these limitations — and the resulting physical inactivity — may further compound the risk of cardiovascular disease as the survivors age. Survivors of CNS tumors — who often have significant cognitive, visual, and auditory impairment and endocrinopathies — are the group most likely to be functionally impaired.6,19-21 Hodgkin's disease survivors have the highest risk of second cancers and heart disease.22-27
Five treatment combinations were associated with a risk of severe or life-threatening conditions that was increased by a factor of at least 10; four of the treatment combinations included chest, abdominal, or pelvic irradiation. Survivors who were treated with any of these combinations should be identified for the purpose of surveillance, since many of the conditions can be diagnosed at an early and treatable stage (e.g., breast cancer, cardiomyopathy, and osteoporosis).28
As compared with men, women who survive childhood cancer have been reported to have a greater risk of diminished health status,6 second cancers,22,29 anthracycline-related cardiomyopathy and congestive heart failure,30 and cranial radiotherapy–related cognitive dysfunction, growth hormone deficiency, and obesity.31-34 Our study confirms this difference in outcomes between the sexes after cancer therapy. It has been reported that less than 20% of adult survivors of childhood cancer are followed at a cancer center or by an oncologist; the likelihood of follow-up in this setting decreases even more with time.35 For this reason, it is important for general physicians and internists to be aware of the risks facing this population.
There are several considerations to keep in mind when interpreting these findings. First, the conditions were self-reported without external verification, with the exception of second cancers and death. Several key chronic conditions associated with cancer therapy, such as late-onset cardiomyopathy associated with previous anthracycline exposure, may remain clinically silent for long periods before becoming clinically apparent.36 Other conditions that may be underreported are osteoporosis, hypertension, and insulin resistance. Our list of chronic conditions, although comprehensive, is not all-inclusive; a notable omission is adverse mental health outcomes, an important component of morbidity after cancer in childhood.6,37,38
In summary, adult survivors of pediatric cancer who were treated in the 1970s and 1980s are a high-risk population. Thirty years after a diagnosis of cancer, almost three fourths of survivors have a chronic health condition, more than 40% have a serious health problem, and one third have multiple conditions. The incidence of health conditions reported by this population increases with time and does not appear to plateau. The monitoring of survivors is an important part of their overall health care.
Presented at the Proceedings of the 2005 Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, May 13–17, 2005.
Supported by a grant (U24-CA-55727, to Dr. Robison) from the Department of Health and Human Services; by the Children's Cancer Research Fund (to the University of Minnesota); and by American Lebanese Syrian Associated Charities (St. Jude Children's Research Hospital).
No potential conflict of interest relevant to this article was reported.
Source Information
From Memorial Sloan-Kettering Cancer Center, New York (K.C.O., C.A.S.); the University of Minnesota, Minneapolis (A.C.M.); the Fred Hutchinson Cancer Research Center, Seattle (T.K., D.L.F., W.L.); St. Jude Children's Research Hospital, Memphis, TN (M.M.H., L.L.R.); Children's Hospital of Philadelphia, Philadelphia (A.T.M., W.H.); Stanford University Medical Center, Palo Alto, CA (N.M.); Yale University School of Medicine, New Haven, CT (N.S.K.-L.); and Brown Medical School, Providence, RI (C.L.S.).
Address reprint requests to Dr. Oeffinger at the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, or at oeffingk@mskcc.org.
Members of the Childhood Cancer Survivor Study are listed in the Appendix.
Appendix
The following investigators are members of the Childhood Cancer Survivor Study Group: University of California, San Francisco — R. Goldsby (principal investigator), A. Ablin (former principal investigator); University of Alabama, Birmingham — R. Berkow (principal investigator); International Epidemiology Institute, Rockville, MD — J. Boice (steering committee); University of Washington, Seattle — N. Breslow (steering committee); University of Texas Southwestern Medical Center, Dallas — G. Tomlinson (principal investigator), G.R. Buchanan (former principal investigator); Cincinnati Children's Hospital Medical Center, Cincinnati — S. Davies (steering committee); Dana–Farber Cancer Institute, Boston — L. Diller (principal investigator), H. Grier (former principal investigator), F. Li (steering committee); Texas Children's Center, Houston — Z. Dreyer (principal investigator); Children's Hospital and Medical Center, Seattle — D. Friedman (principal investigator), T. Pendergrass (former principal investigator); Roswell Park Cancer Institute, Buffalo, NY — D.M. Green (principal investigator and steering committee); Hospital for Sick Children, Toronto — M. Greenberg (principal investigator); St. Louis Children's Hospital, St. Louis — R. Hayashi (principal investigator), T. Vietti (former principal investigator); St. Jude Children's Research Hospital, Memphis, TN — L.L. Robison (principal investigator and steering committee), M. Hudson (principal investigator and steering committee); University of Michigan, Ann Arbor — R. Hutchinson (principal investigator); Stanford University School of Medicine, Stanford, CA — N. Marina (principal investigator), M.P. Link (former principal investigator), S.S. Donaldson (steering committee); Emory University, Atlanta — L. Meacham (principal investigator); Children's Hospital of Philadelphia, Philadelphia — A. Meadows (principal investigator and steering committee), B. Bayton (steering committee); Children's Hospital, Oklahoma City — J. Mulvihill (steering committee); Children's Hospital, Denver — B. Greffe (principal investigator), L. Odom (former principal investigator); Children's Health Care-Minneapolis, Minneapolis — J. Perkins (principal investigator), M. O'Leary (former principal investigator); Columbus Children's Hospital, Columbus, OH — A. Termuhlen (principal investigator), F. Ruymann (former principal investigator), S. Qualman (steering committee); Children's National Medical Center, Washington, DC — G. Reaman (principal investigator), R. Packer (steering committee); Children's Hospital of Pittsburgh, Pittsburgh — A. Ritchey (principal investigator), J. Blatt (former principal investigator); University of Minnesota, Minneapolis — A. Mertens (principal investigator and steering committee), J. Neglia (steering committee), M. Nesbit (steering committee); Children's Hospital Los Angeles, Los Angeles — K. Ruccione (principal investigator); Memorial Sloan-Kettering Cancer Center, New York — C. Sklar (principal investigator and steering committee), K. Oeffinger (steering committee); National Cancer Institute, Bethesda, MD — B. Anderson (steering committee), P. Inskip (steering committee); Mayo Clinic, Rochester, MN — V. Rodriguez (principal investigator), W. Smithson (former principal investigator), G. Gilchrist (former principal investigator); University of Texas M.D. Anderson Cancer Center, Houston — L. Strong (principal investigator and steering committee), M. Stovall (steering committee); Riley Hospital for Children, Indianapolis — T.A. Vik (principal investigator), R. Weetman (former principal investigator); Fred Hutchinson Cancer Center, Seattle — W. Leisenring (principal investigator and steering committee), J. Potter (former principal investigator and steering committee); University of Alberta, Edmonton, AB, Canada — Y. Yasui (steering committee); and University of California, Los Angeles — L. Zeltzer (principal investigator and steering committee).
- References
References
1
Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER cancer statistics review, 1975-2002. Bethesda, MD: National Cancer Institute, 2005. (Accessed September 15, 2006, at http://seer.cancer.gov/csr/1975_2002/.)
2
Hewitt M, Weiner SL, Simone JV, eds. Childhood cancer survivorship: improving care and quality of life. Washington, DC: National Academies Press, 2003.
3
Oeffinger KC ,Hudson MM . Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin 2004;54:208-236
CrossRef | Web of Science | Medline4
Friedman DL ,Meadows AT . Late effects of childhood cancer therapy. Pediatr Clin North Am 2002;49:1083-1106
CrossRef | Web of Science | Medline5
Mertens AC ,Yasui Y ,Neglia JP , et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001;19:3163-3172
Web of Science | Medline6
Hudson MM ,Mertens AC ,Yasui Y , et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 2003;290:1583-1592
CrossRef | Web of Science | Medline7
Garre ML ,Gandus S ,Cesana B , et al. Health status of long-term survivors after cancer in childhood: results of an uniinstitutional study in Italy. Am J Pediatr Hematol Oncol 1994;16:143-152
Medline8
Stevens MC ,Mahler H ,Parkes S . The health status of adult survivors of cancer in childhood. Eur J Cancer 1998;34:694-698
CrossRef | Web of Science | Medline9
Sklar CA . Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediatr Suppl 1999;88:1-4
CrossRef | Medline10
Oeffinger KC ,Eshelman DA ,Tomlinson GE ,Buchanan GR ,Foster BM . Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 2000;88:1687-1695
CrossRef | Web of Science | Medline11
Robison LL ,Mertens AC ,Boice JD , et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 2002;38:229-239
CrossRef | Medline12
Mertens AC ,Walls RS ,Taylor L , et al. Characteristics of childhood cancer survivors predicted their successful tracing. J Clin Epidemiol 2004;57:933-944
CrossRef | Web of Science | Medline13
Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0. Bethesda, MD: National Cancer Institute, 2003. (Accessed September 15, 2006, at http://ctep.cancer.gov/reporting/ctc_v30.html.)
14
Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer-Verlag, 2000.
15
Gooley TA ,Leisenring W ,Crowley J ,Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706
CrossRef | Web of Science | Medline16
Eiser C ,Darlington AS ,Stride CB ,Grimer R . Quality of life implications as a consequence of surgery: limb salvage, primary and secondary amputation. Sarcoma 2001;5:189-195
CrossRef | Medline17
Nagarajan R ,Neglia JP ,Clohisy DR ,Robison LL . Limb salvage and amputation in survivors of pediatric lower-extremity bone tumors: what are the long-term implications? J Clin Oncol 2002;20:4493-4501
CrossRef | Web of Science | Medline18
Ness KK ,Mertens AC ,Hudson MM , et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med 2005;143:639-647
Web of Science | Medline19
Mulhern RK ,Hancock J ,Fairclough D ,Kun L . Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol 1992;20:181-191
CrossRef | Medline20
Mulhern RK ,Reddick WE ,Palmer SL , et al. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999;46:834-841
CrossRef | Web of Science | Medline21
Sklar CA ,Constine LS . Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:1113-1121
CrossRef | Web of Science | Medline22
Bhatia S ,Yasui Y ,Robison LL , et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 2003;21:4386-4394
CrossRef | Web of Science | Medline23
Bisharat N ,Omari H ,Lavi I ,Raz R . Risk of infection and death among post-splenectomy patients. J Infect 2001;43:182-186
CrossRef | Web of Science | Medline24
Travis LB ,Gospodarowicz M ,Curtis RE , et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002;94:182-192
CrossRef | Web of Science | Medline25
Hull MC ,Morris CG ,Pepine CJ ,Mendenhall NP . Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003;290:2831-2837
CrossRef | Web of Science | Medline26
Kenney LB ,Yasui Y ,Inskip PD , et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004;141:590-597
Web of Science | Medline27
Ng AK ,Mauch PM . Late complications of therapy of Hodgkin's disease: prevention and management. Curr Hematol Rep 2004;3:27-33
Medline28
Oeffinger KC . Longitudinal risk-based health care for adult survivors of childhood cancer. Curr Probl Cancer 2003;27:143-167
CrossRef | Medline29
Neglia JP ,Friedman DL ,Yasui Y , et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 2001;93:618-629
CrossRef | Web of Science | Medline30
Lipshultz SE ,Lipsitz SR ,Mone SM , et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995;332:1738-1743
Full Text | Web of Science | Medline31
Waber DP ,Tarbell NJ ,Fairclough D , et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 1995;13:2490-2496
Web of Science | Medline32
Robison LL ,Nesbit ME Jr ,Sather HN ,Meadows AT ,Ortega JA ,Hammond GD . Height of children successfully treated for acute lymphoblastic leukemia: a report from the Late Effects Study Committee of Childrens Cancer Study Group. Med Pediatr Oncol 1985;13:14-21
CrossRef | Medline33
Melin AE ,Adan L ,Leverger G ,Souberbielle JC ,Schaison G ,Brauner R . Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemia. Eur J Pediatr 1998;157:703-707
CrossRef | Web of Science | Medline34
Oeffinger KC ,Mertens AC ,Sklar CA , et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003;21:1359-1365
CrossRef | Web of Science | Medline35
Oeffinger KC ,Mertens AC ,Hudson MM , et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med 2004;2:61-70
CrossRef | Web of Science | Medline36
Lipshultz SE ,Lipsitz SR ,Sallan SE , et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005;23:2629-2636
CrossRef | Web of Science | Medline37
Zebrack BJ ,Gurney JG ,Oeffinger K , et al. Psychological outcomes in long-term survivors of childhood brain cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2004;22:999-1006
CrossRef | Web of Science | Medline38
Zebrack BJ ,Zeltzer LK ,Whitton J , et al. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma: a report from the Childhood Cancer Survivor Study. Pediatrics 2002;110:42-52
CrossRef | Web of Science | Medline
- Citing Articles (361)
Citing Articles
1
E. Sieswerda, A. Postma, E. C. van Dalen, H. J. H. van der Pal, W. J. E. Tissing, L. A. J. Rammeloo, W. E. M. Kok, F. E. van Leeuwen, H. N. Caron, L. C. M. Kremer, . (2012) The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Annals of Oncology
CrossRef2
Straus, David J., . (2012) Chemotherapy Alone for Early-Stage Hodgkin's Lymphoma. New England Journal of Medicine 366:5, 470-471
Full Text3
M. H. Bornstein, S. Scrimin, D. L. Putnick, F. Capello, O. M. Haynes, S. de Falco, M. Carli, M. Pillon. (2012) Neurodevelopmental Functioning in Very Young Children Undergoing Treatment for Non-CNS Cancers. Journal of Pediatric Psychology
CrossRef4
M. Vesterbacka, O. Ringdén, M. Remberger, J. Huggare, G. Dahllöf. (2012) Disturbances in dental development and craniofacial growth in children treated with hematopoietic stem cell transplantation. Orthodontics & Craniofacial Research 15:1, 21-29
CrossRef5
Joseph Wiemels. (2012) Perspectives on the Causes of Childhood Leukemia. Chemico-Biological Interactions
CrossRef6
Harvey Jay Cohen, Lan Lan, Laura Archer, Alice B. Kornblith. (2012) Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803). Journal of Geriatric Oncology
CrossRef7
Aziza Shad, Scott N. Myers, Karen Hennessy. (2012) Late Effects in Cancer Survivors: “The Shared Care Model”. Current Oncology Reports
CrossRef8
E L Carpenter, E A Haglund, E M Mace, D Deng, D Martinez, A C Wood, A K Chow, D A Weiser, L T Belcastro, C Winter, S C Bresler, S Asgharzadeh, R C Seeger, H Zhao, R Guo, J G Christensen, J S Orange, B R Pawel, M A Lemmon, Y P Mossé. (2012) Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma. Oncogene
CrossRef9
Emily S. Tonorezos, Gloria L. Vega, Charles A. Sklar, Joanne F. Chou, Chaya S. Moskowitz, Qianxing Mo, Timothy S. Church, Robert Ross, Peter M. Janiszewski, Kevin C. Oeffinger. (2012) Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatric Blood & Cancer 58:1, 31-36
CrossRef10
Michael A. Pulsipher, Roderick Skinner, George B. McDonald, Sangeeta Hingorani, Saro H. Armenian, Kenneth R. Cooke, Clarisa Gracia, Anna Petryk, Smita Bhatia, Nancy Bunin, Michael L. Nieder, Christopher C. Dvorak, Lillian Sung, Jean E. Sanders, Joanne Kurtzberg, K. Scott Baker. (2012) NCI, NHLBI/PBMTC First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: The Need for Pediatric Specific Long Term Follow-up Guidelines. Biology of Blood and Marrow Transplantation
CrossRef11
William Furlong, Charlene Rae, David Feeny, Richard D. Gelber, Caroline Laverdiere, Bruno Michon, Lewis Silverman, Stephen Sallan, Ronald Barr. (2012) Health-related quality of life among children with acute lymphoblastic leukemia. Pediatric Blood & Cancern/a-n/a
CrossRef12
Hiromi Hyodo, Hiroyuki Ishiguro, Yuichiro Tomita, Hiromitsu Takakura, Takashi Koike, Takashi Shimizu, Tsuyoshi Morimoto, Hiromasa Yabe, Miharu Yabe, Sei-ichiro Kojima, Koichi Shiraishi, Takashi Minemura, Shunichi Kato. (2012) Decreased serum testosterone levels in long-term adult survivors with fatty liver after childhood stem cell transplant. Biology of Blood and Marrow Transplantation
CrossRef13
Rhonda S. Robert, Raheem J. Paxton, Shana L. Palla, Grace Yang, Martha A. Askins, Shaini E. Joy, Joann L. Ater. (2012) Feasibility, reliability, and validity of the pediatric quality of life inventory™ generic core scales, cancer module, and multidimensional fatigue scale in long-term adult survivors of pediatric cancer. Pediatric Blood & Cancern/a-n/a
CrossRef14
Min-Ah Kim, Jae-hee Yi. (2012) Childhood Cancer Survivor's Services Needs for the Better Quality of Life. Journal of Korean Academy of Child Health Nursing 18:1, 19
CrossRef15
Lamia P. Barakat, Lisa A. Schwartz, Margo M. Szabo, Heather M. Hussey, Greta R. Bunin. (2011) Factors that contribute to post-treatment follow-up care for survivors of childhood cancer. Journal of Cancer Survivorship
CrossRef16
Lene Molgaard-Hansen, Heidi Glosli, Kirsi Jahnukainen, Marianne Jarfelt, Guðmundur K. Jónmundsson, Johan Malmros-Svennilson, Karsten Nysom, Henrik Hasle, . (2011) Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO-AML study. Pediatric Blood & Cancer 57:7, 1222-1229
CrossRef17
Christopher Fryer. (2011) Late effects in childhood cancer survivors: A review with a framing effect bias?. Pediatric Blood & Cancer 57:7, 1100-1103
CrossRef18
Alicia Kunin-Batson, Nina Kadan-Lottick, Liang Zhu, Cheryl Cox, Veronica Bordes-Edgar, Deo Kumar Srivastava, Lonnie Zeltzer, Leslie L. Robison, Kevin R. Krull. (2011) Predictors of independent living status in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Pediatric Blood & Cancer 57:7, 1197-1203
CrossRef19
Amanda M. Termuhlen, Jean M. Tersak, Qi Liu, Yutaka Yasui, Marilyn Stovall, Rita Weathers, Melvin Deutsch, Charles A. Sklar, Kevin C. Oeffinger, Greg Armstrong, Leslie L. Robison, Daniel M. Green. (2011) Twenty-five year follow-up of childhood Wilms tumor: A report from the Childhood Cancer Survivor Study. Pediatric Blood & Cancer 57:7, 1210-1216
CrossRef20
Paul C. Nathan, Joshua D. Schiffman, Sujuan Huang, Wendy Landier, Smita Bhatia, Debra Eshelman-Kent, Jennifer Wright, Kevin C. Oeffinger, Melissa M. Hudson. (2011) Childhood cancer survivorship educational resources in North American pediatric hematology/oncology fellowship training programs: A survey study. Pediatric Blood & Cancer 57:7, 1186-1190
CrossRef21
Anthony Penn, Stephen P. Lowis, Michael C.G. Stevens, Robert I. Shortman, Linda P. Hunt, Renee J. McCarter, Andrew L. Curran, Peta M. Sharples. (2011) A Detailed Prospective Longitudinal Assessment of Health Status in Children With Brain Tumors in the First Year After Diagnosis. Journal of Pediatric Hematology/Oncology 33:8, 592-599
CrossRef22
Raphaële R.L. van Litsenburg, Carin A. Uyl-de Groot, Hein Raat, Gertjan J.L. Kaspers, Reinoud J.B.J. Gemke. (2011) Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: The influence of new medication and diagnostic technology. Pediatric Blood & Cancer 57:6, 1005-1010
CrossRef23
Lisa B. Kenney, Heather Bradeen, Nina S. Kadan-Lottick, Lisa Diller, Alan Homans, Cindy L. Schwartz. (2011) The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: A report from the consortium for New England childhood cancer survivors. Pediatric Blood & Cancer 57:6, 1062-1066
CrossRef24
A. Paumier, W. Khodari, A. Beaudre, M. Ghalibafian, P. Blanchard, H. Al Hamokles, M. Bhari, N. Lessard, T. Girinsky. (2011) Optimisation de l’« involved-node radiotherapy » par l’utilisation de la modulation d’intensité dans le lymphome hodgkinien localisé : expérience de l’institut Gustave-Roussy. Cancer/Radiothérapie 15:8, 709-715
CrossRef25
Pippa G. Corrie. (2011) Cytotoxic chemotherapy: clinical aspects. Medicine 39:12, 717-722
CrossRef26
Margaret McLaughlin, Yujung Nam, Jessica Gould, Courtney Pade, Kathleen A. Meeske, Kathleen S. Ruccione, Janet Fulk. (2011) A videosharing social networking intervention for young adult cancer survivors. Computers in Human Behavior
CrossRef27
Takashi Koike, Noriharu Yanagimachi, Hiroyuki Ishiguro, Hiromasa Yabe, Miharu Yabe, Tsuyoshi Morimoto, Takashi Shimizu, Hiromitsu Takakura, Shunichi Kato. (2011) High incidence of radiation induced cavernous hemangioma in long-term survivors who underwent hematopoietic stem cell transplantation with radiation therapy during childhood or adolescence. Biology of Blood and Marrow Transplantation
CrossRef28
Joanna L. Meadors, Yonghzi Cui, Qing-Rong Chen, Young K. Song, Javed Khan, Glenn Merlino, Maria Tsokos, Rimas J. Orentas, Crystal L. Mackall. (2011) Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy. Pediatric Blood & Cancer 57:6, 921-929
CrossRef29
L. L. Robison. (2011) Late Effects of Acute Lymphoblastic Leukemia Therapy in Patients Diagnosed at 0-20 Years of Age. Hematology 2011:1, 238-242
CrossRef30
R. Blaauwbroek, H. A. Barf, K. H. Groenier, L. C. Kremer, K. Meer, W. J. E. Tissing, A. Postma. (2011) Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan. Journal of Cancer Survivorship
CrossRef31
I-Chan Huang, Gwendolyn P. Quinn, Pey-Shan Wen, Elizabeth A. Shenkman, Dennis A. Revicki, Kevin Krull, Zhushan Li, Patricia D. Shearer. (2011) Using three legacy measures to develop a health-related quality of life tool for young adult survivors of childhood cancer. Quality of Life Research
CrossRef32
C. L. Carbonneau, G. Despars, S. Rojas-Sutterlin, A. Fortin, O. Le, T. Hoang, C. M. Beausejour. (2011) Ionizing radiation-induced expression of INK4a/ARF in murine bone marrow-derived stromal cell populations interferes with bone marrow homeostasis. Blood
CrossRef33
N F Khan, D Mant, L Carpenter, D Forman, P W Rose. (2011) Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. British Journal of Cancer 105, S29-S37
CrossRef34
J Maher, H McConnell. (2011) New pathways of care for cancer survivors: adding the numbers. British Journal of Cancer 105, S5-S10
CrossRef35
Jacqueline Casillas, Karen L. Syrjala, Patricia A. Ganz, Emy Hammond, Alfred C. Marcus, Kerry M. Moss, Catherine M. Crespi, Peiyun Lu, Mary S. McCabe, Jennifer S. Ford, Linda A. Jacobs, Donna Pucci, Steven C. Palmer, Amanda M. Termuhlen, Lisa Diller, Marci Campbell, Barbara Jones, Debra L. Friedman. (2011) How confident are young adult cancer survivors in managing their survivorship care? A report from the LIVESTRONG™ Survivorship Center of Excellence Network. Journal of Cancer Survivorship
CrossRef36
Cornelia A.J. Brouwer, Aleida Postma, Judith M. Vonk, Nynke Zwart, Maarten P. van den Berg, Margreet Th.E. Bink-Boelkens, Wil V. Dolsma, Andries J. Smit, Elisabeth G.E. de Vries, W.J.E. Tissing, Jourik A. Gietema. (2011) Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer. European Journal of Cancer 47:16, 2453-2462
CrossRef37
John Breneman, Jane Meza, Sarah S. Donaldson, R. Beverly Raney, Suzanne Wolden, Jeff Michalski, Fran Laurie, David A. Rodeberg, William Meyer, David Walterhouse, Douglas S. Hawkins. (2011) Local Control with Reduced-Dose Radiotherapy for Low-Risk Rhabdomyosarcoma: A Report from the Children’s Oncology Group D9602 Study. International Journal of Radiation Oncology*Biology*Physics
CrossRef38
Michael L. Nieder, George B. McDonald, Aiko Kida, Sangeeta Hingorani, Saro H. Armenian, Kenneth R. Cooke, Michael A. Pulsipher, K. Scott Baker. (2011) National Cancer Institute–National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Long-Term Organ Damage and Dysfunction. Biology of Blood and Marrow Transplantation 17:11, 1573-1584
CrossRef39
Hyun-Suk Jung, Seung-Kwon Myung, Byung-Su Kim, Hong Gwan Seo. (2011) Metabolic syndrome in adult cancer survivors: A meta-analysis. Diabetes Research and Clinical Practice
CrossRef40
C. E. Kuehni, C. S. Rueegg, G. Michel, C. E. Rebholz, M.-P. F. Strippoli, F. K. Niggli, M. Egger, N. X. von der Weid, . (2011) Cohort profile: The Swiss Childhood Cancer Survivor Study. International Journal of Epidemiology
CrossRef41
M. B. Gilliam, A. Madan-Swain, K. Whelan, D. C. Tucker, W. Demark-Wahnefried, D. C. Schwebel. (2011) Social, Demographic, and Medical Influences on Physical Activity in Child and Adolescent Cancer Survivors. Journal of Pediatric Psychology
CrossRef42
Diller, Lisa, . (2011) Adult Primary Care after Childhood Acute Lymphoblastic Leukemia. New England Journal of Medicine 365:15, 1417-1424
Full Text43
Shizuka Watanabe, Yuriko Azami, Miwa Ozawa, Takahiro Kamiya, Daisuke Hasegawa, Chitose Ogawa, Yasushi Ishida, Ryota Hosoya, Junko Kizu, Atsushi Manabe. (2011) Intellectual development after treatment in children with acute leukemia and brain tumor. Pediatrics International 53:5, 694-700
CrossRef44
Richard A. Anderson, W. Hamish B. Wallace. (2011) Fertility preservation in girls and young women. Clinical Endocrinology 75:4, 409-419
CrossRef45
K Garming-Legert, M Remberger, O Ringdén, M Hassan, G Dahllöf. (2011) Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI. Oral Diseases 17:7, 670-676
CrossRef46
Lisa A. Schwartz, Anne E. Kazak, Branlyn W. DeRosa, Matthew C. Hocking, Wendy L. Hobbie, Jill P. Ginsberg. (2011) The Role of Beliefs in the Relationship Between Health Problems and Posttraumatic Stress in Adolescent and Young Adult Cancer Survivors. Journal of Clinical Psychology in Medical Settings
CrossRef47
Eline J. Aukema, Bob F. Last, A. Y. Netteke Schouten-van Meeteren, Martha A. Grootenhuis. (2011) Explorative study on the aftercare of pediatric brain tumor survivors: a parents’ perspective. Supportive Care in Cancer 19:10, 1637-1646
CrossRef48
Bradford S. Hoppe, Stella Flampouri, Zhong Su, Christopher G. Morris, Naeem Latif, Nam H. Dang, James Lynch, Zuofeng Li, Nancy P. Mendenhall. (2011) Consolidative Involved-Node Proton Therapy for Stage IA-IIIB Mediastinal Hodgkin Lymphoma: Preliminary Dosimetric Outcomes from a Phase II Study. International Journal of Radiation Oncology*Biology*Physics
CrossRef49
Gisela Michel, Claudia E. Kuehni, Cornelia E. Rebholz, Karin Zimmermann, Christine Eiser, Corina S. Rueegg, Nicolas X. von der Weid, . (2011) Can health beliefs help in explaining attendance to follow-up care? The Swiss Childhood Cancer Survivor Study. Psycho-Oncology 20:10, 1034-1043
CrossRef50
K. Scott Baker, Smita Bhatia, Nancy Bunin, Michael Nieder, Christopher C. Dvorak, Lillian Sung, Jean E. Sanders, Joanne Kurtzberg, Michael A. Pulsipher. (2011) NCI, NHLBI First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: State of the Science, Future Directions. Biology of Blood and Marrow Transplantation 17:10, 1424-1427
CrossRef51
Emma Hovén, Birgitta Lannering, Göran Gustafsson, Krister K. Boman. (2011) The met and unmet health care needs of adult survivors of childhood central nervous system tumors. Cancer 117:18, 4294-4303
CrossRef52
W. van Dorp, R. D. van Beek, J. S. E. Laven, R. Pieters, S. M. P. F. de Muinck Keizer-Schrama, M. M. van den Heuvel-Eibrink. (2011) Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review. Human Reproduction Update
CrossRef53
Debra Eshelman-Kent, Karen E. Kinahan, Wendy Hobbie, Wendy Landier, Steve Teal, Debra Friedman, Rajaram Nagarajan, David R. Freyer. (2011) Cancer survivorship practices, services, and delivery: a report from the Children’s Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees. Journal of Cancer Survivorship
CrossRef54
Göran Dahllöf, Biniyam Wondimu, Monica Barr-Agholme, Karin Garming-Legert, Mats Remberger, Olle Ringdén. (2011) Xerostomia in children and adolescents after stem cell transplantation conditioned with total body irradiation or busulfan. Oral Oncology 47:9, 915-919
CrossRef55
Francesco Felicetti, Rosaria Manicone, Andrea Corrias, Chiara Manieri, Eleonora Biasin, Ilaria Bini, Giuseppe Boccuzzi, Enrico Brignardello. (2011) Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution. Journal of Cancer Research and Clinical Oncology 137:9, 1343-1348
CrossRef56
Aric Bendorf, Ian H Kerridge. (2011) Ethical issues in bone marrow transplantation in children. Journal of Paediatrics and Child Health 47:9, 614-619
CrossRef57
Emma I. Hovén, Birgitta Lannering, Göran Gustafsson, Krister K. Boman. (2011) Persistent impact of illness on families of adult survivors of childhood central nervous system tumors: a population-based cohort study. Psycho-Oncologyn/a-n/a
CrossRef58
D. J. Straus. (2011) Chemotherapy only for localized Hodgkin lymphoma. Journal of Internal Medicine 270:3, 197-205
CrossRef59
Darren Mays, Jessica Donze Black, Revonda B. Mosher, Aziza T. Shad, Kenneth P. Tercyak. (2011) Improving short-term sun safety practices among adolescent survivors of childhood cancer: a randomized controlled efficacy trial. Journal of Cancer Survivorship 5:3, 247-254
CrossRef60
Karen L. Syrjala, Allison C. Stover, Jean C. Yi, Samantha B. Artherholt, Eleni M. Romano, Gary Schoch, Susan Stewart, Mary E. D. Flowers. (2011) Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation. Journal of Cancer Survivorship 5:3, 292-304
CrossRef61
B. L. Laskin, J. Goebel, S. M. Davies, S. Jodele. (2011) Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118:6, 1452-1462
CrossRef62
S. H. Armenian, C.-L. Sun, T. Kawashima, M. Arora, W. Leisenring, C. A. Sklar, K. S. Baker, L. Francisco, J. B. Teh, G. Mills, F. L. Wong, J. Rosenthal, L. R. Diller, M. M. Hudson, K. C. Oeffinger, S. J. Forman, L. L. Robison, S. Bhatia. (2011) Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 118:5, 1413-1420
CrossRef63
Matthew C. Hocking, Wendy L. Hobbie, Janet A. Deatrick, Matthew S. Lucas, Margo M. Szabo, Ellen M. Volpe, Lamia P. Barakat. (2011) Neurocognitive and Family Functioning and Quality of Life Among Young Adult Survivors of Childhood Brain Tumors. The Clinical Neuropsychologist 25:6, 942-962
CrossRef64
Kim Edelstein, Norma DʼAgostino, Lori J. Bernstein, Paul C. Nathan, Mark L. Greenberg, David C. Hodgson, Barbara Ann Millar, Normand Laperriere, Brenda J. Spiegler. (2011) Long-term Neurocognitive Outcomes in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 33:6, 450-458
CrossRef65
Amy Kennedy, Andrew Toogood. (2011) What’s new in…. Medicine 39:8, 502-505
CrossRef66
Amy A. Pruitt. (2011) Medical Management of Patients With Brain Tumors. Current Treatment Options in Neurology 13:4, 413-426
CrossRef67
Gisela Michel, Diana Greenfield, Kate Absolom, Christine Eiser, . (2011) Satisfaction with follow-up consultations among younger adults treated for cancer: the role of quality of life and psychological variables. Psycho-Oncology 20:8, 813-822
CrossRef68
Darren Mays, Jessica Donze Black, Revonda B. Mosher, Allison Heinly, Aziza T. Shad, Kenneth P. Tercyak. (2011) Efficacy of the Survivor Health and Resilience Education (SHARE) Program to Improve Bone Health Behaviors Among Adolescent Survivors of Childhood Cancer. Annals of Behavioral Medicine 42:1, 91-98
CrossRef69
Kimberly Whelan, Kayla Stratton, Toana Kawashima, Wendy Leisenring, Susan Hayashi, John Waterbor, Julie Blatt, Charles A. Sklar, Roger Packer, Pauline Mitby, Leslie L. Robison, Ann C. Mertens. (2011) Auditory complications in childhood cancer survivors: A report from the childhood cancer survivor study. Pediatric Blood & Cancer 57:1, 126-134
CrossRef70
Renée L Mulder, Elvira C van Dalen, Malon Van den Hof, Dorine Bresters, Bart GP Koot, Sharon M Castellino, Yoon Loke, Edith Leclercq, Piet N Post, Huib N Caron, Aleida Postma, Leontien CM Kremer, Renée L Mulder. 2011. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. .
CrossRef71
R. Dopfer. (2011) Familienorientierte hämatoonkologische Rehabilitation. Monatsschrift Kinderheilkunde 159:7, 642-649
CrossRef72
Minsig Choi, Barbara Craft, Stephen A. Geraci. (2011) Surveillance and Monitoring of Adult Cancer Survivors. The American Journal of Medicine 124:7, 598-601
CrossRef73
Gerald Rosen, Sarah R. Brand. (2011) Sleep in children with cancer: case review of 70 children evaluated in a comprehensive pediatric sleep center. Supportive Care in Cancer 19:7, 985-994
CrossRef74
A.B. Edgar, S. Borthwick, K. Duffin, P. Marciniak-Stepak, W.H.B. Wallace. (2011) Survivors of childhood cancer lost to follow-up can be re-engaged into active long-term follow-up by a postal health questionnaire intervention. European Journal of Cancer
CrossRef75
Akm Hossain, Alice Chen, Percy Ivy, Daniel J. Lenihan, Jonathan Kaltman, Wendy Taddei-Peters, Scot C. Remick. (2011) The Importance of Clinical Grading of Heart Failure and Other Cardiac Toxicities During Chemotherapy: Updating the Common Terminology Criteria for Clinical Trial Reporting. Heart Failure Clinics 7:3, 373-384
CrossRef76
Jaime Feliu, Juan Antonio Virizuela. (2011) El seguimiento en los supervivientes de cáncer: una responsabilidad compartida. Medicina Clínica 137:4, 163-165
CrossRef77
K S Baker, E Chow, J Steinberger. (2011) Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplantation
CrossRef78
Pierantonio Menna, Odalys Gonzalez Paz, Massimo Chello, Elvio Covino, Emanuela Salvatorelli, Giorgio Minotti. (2011) Anthracycline cardiotoxicity. Expert Opinion on Drug Safety1-16
CrossRef79
Nancy R. Clanton, James L. Klosky, Chenghong Li, Neelam Jain, Deo Kumar Srivastava, Daniel Mulrooney, Lonnie Zeltzer, Marilyn Stovall, Leslie L. Robison, Kevin R. Krull. (2011) Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer. Cancer 117:11, 2559-2568
CrossRef80
Kevin R. Krull, Robert D. Annett, Zhenyu Pan, Kirsten K. Ness, Paul C. Nathan, Deo Kumar Srivastava, Marilyn Stovall, Leslie L. Robison, Melissa M. Hudson. (2011) Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. European Journal of Cancer 47:9, 1380-1388
CrossRef81
Wayne D. Newhauser, Marco Durante. (2011) Assessing the risk of second malignancies after modern radiotherapy. Nature Reviews Cancer 11:6, 438-448
CrossRef82
Stefano Oliva, Agnese Maria Fioretti. (2011) Cardiovascular complications of conventional anticancer therapy. Journal of Cardiovascular Echography 21:2, 73-77
CrossRef83
Yasushi Ishida, Shuichi Ozono, Naoko Maeda, Jun Okamura, Keiko Asami, Tsuyako Iwai, Kiyoko Kamibeppu, Naoko Sakamoto, Naoko Kakee, Keizo Horibe. (2011) Medical visits of childhood cancer survivors in Japan: A cross-sectional survey. Pediatrics International 53:3, 291-299
CrossRef84
Amaury Paumier, Mithra Ghalibafian, Jennifer Gilmore, Anne Beaudre, Pierre Blanchard, Mohammed el Nemr, Farez Azoury, Hweej al Hamokles, Dimitri Lefkopoulos, Theodore Girinsky. (2011) Dosimetric Benefits of Intensity-Modulated Radiotherapy Combined with the Deep-Inspiration Breath-Hold Technique in Patients with Mediastinal Hodgkin’s Lymphoma. International Journal of Radiation Oncology*Biology*Physics
CrossRef85
Lisa M. Bashore. (2011) Young Adults with Risk Factors for Chronic Disease: Transition Needs for Survivors of Childhood Cancer. Critical Care Nursing Clinics of North America 23:2, 311-322
CrossRef86
Lidia Boccardi, Fabiola Fini, Paolo Giuseppe Pino, Giovanni Minardi. (2011) Cardiopatie e rischio cardiovascolare in pazienti candidati alla terapia antitumorale. Che cosa deve sapere l’oncologo. Journal of Cardiovascular Echography 21:2, 45-54
CrossRef87
D. J. Straus, J. L. Johnson, A. S. LaCasce, N. L. Bartlett, L. Kostakoglu, E. D. Hsi, H. Schoder, N. C. Hall, S.-H. Jung, G. P. Canellos, L. H. Schwartz, R. W. Takvorian, M. E. Juweid, B. D. Cheson, . (2011) Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood 117:20, 5314-5320
CrossRef88
Mark Greenberg, Anne Klassen, Amiram Gafni, Mary L McBride, Karen Albritton. (2011) Outcomes and metrics. Cancer 117:S10, 2342-2350
CrossRef89
Emily S. Tonorezos, Kevin C. Oeffinger. (2011) Research challenges in adolescent and young adult cancer survivor research. Cancer 117:S10, 2295-2300
CrossRef90
Ronald D. Barr. (2011) Adolescents, young adults, and cancer-the international challenge. Cancer 117:S10, 2245-2249
CrossRef91
Kevin C. Oeffinger, Emily S. Tonorezos. (2011) The cancer is over, now what?. Cancer 117:S10, 2250-2257
CrossRef92
Melissa M. Hudson, Kirsten K. Ness, Vikki G. Nolan, Gregory T. Armstrong, Daniel M. Green, E. Brannon Morris, Sheri L. Spunt, Monika L. Metzger, Kevin R. Krull, James L. Klosky, Deo Kumar Srivastava, Leslie L. Robison. (2011) Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study. Pediatric Blood & Cancer 56:5, 825-836
CrossRef93
Jacqueline Casillas, Sharon M. Castellino, Melissa M. Hudson, Ann C. Mertens, Isac S. F. Lima, Qi Liu, Lonnie K. Zeltzer, Yutaka Yasui, Leslie L. Robison, Kevin C. Oeffinger. (2011) Impact of insurance type on survivor-focused and general preventive health care utilization in adult survivors of childhood cancer. Cancer 117:9, 1966-1975
CrossRef94
Mara H. Sherman, Craig H. Bassing, Michael A. Teitell. (2011) Regulation of cell differentiation by the DNA damage response. Trends in Cell Biology 21:5, 312-319
CrossRef95
K. Edelstein, B. J. Spiegler, S. Fung, T. Panzarella, D. J. Mabbott, N. Jewitt, N. M. D'Agostino, W. P. Mason, E. Bouffet, U. Tabori, N. Laperriere, D. C. Hodgson. (2011) Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes. Neuro-Oncology 13:5, 536-545
CrossRef96
Amaury Paumier, Mithra Ghalibafian, Anne Beaudre, Ivaldo Ferreira, Charlotte Pichenot, Taha Messai, Nathalie Athalie Lessard, Dimitri Lefkopoulos, Theodore Girinsky. (2011) Involved-Node Radiotherapy and Modern Radiation Treatment Techniques in Patients With Hodgkin Lymphoma. International Journal of Radiation Oncology*Biology*Physics 80:1, 199-205
CrossRef97
Kevin C. Oeffinger, Melissa M. Hudson, Ann C. Mertens, Stephanie M. Smith, Pauline A. Mitby, Debra A. Eshelman-Kent, Jennifer S. Ford, Judith K. Jones, Sharmila Kamani, Leslie L. Robison. (2011) Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatric Blood & Cancer 56:5, 818-824
CrossRef98
Yasushi Ishida, Misato Honda, Kiyoko Kamibeppu, Shuichi Ozono, Jun Okamura, Keiko Asami, Naoko Maeda, Naoko Sakamoto, Hiroko Inada, Tsuyako Iwai, Naoko Kakee, Keizo Horibe. (2011) Social outcomes and quality of life of childhood cancer survivors in Japan: a cross-sectional study on marriage, education, employment and health-related QOL (SF-36). International Journal of Hematology 93:5, 633-644
CrossRef99
Nancy Chen, Lauren Hanly, Michael Rieder, Herman Yeger, Gideon Koren. (2011) The effect of N -acetylcysteine on the antitumor activity of ifosfamide. Canadian Journal of Physiology and Pharmacology 89:5, 335-343
CrossRef100
Paolo Paolucci, Vera Cioni, Elena Bigi, Laura Lucaccioni, Carmen Cano. (2011) Endpoints in paediatric oncology. European Journal of Clinical Pharmacology 67:S1, 33-40
CrossRef101
C. Oudin, M.-C. Simeoni, N. Sirvent, A. Contet, A. Begu-Le Coroller, P. Bordigoni, C. Curtillet, M. Poiree, I. Thuret, B. Play, M. C. Massot, P. Chastagner, H. Chambost, P. Auquier, G. Michel. (2011) Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 117:17, 4442-4448
CrossRef102
Maria F. Lorenzi, Lijing Xie, Paul C. Rogers, Sheila Pritchard, Karen Goddard, Mary L. McBride. (2011) Hospital-related morbidity among childhood cancer survivors in British Columbia, Canada: Report of the childhood, adolescent, young adult cancer survivors (CAYACS) program. International Journal of Cancer 128:7, 1624-1631
CrossRef103
Kirsten K Ness, Saro H Armenian, Nina Kadan-Lottick, James G Gurney. (2011) Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Review of Hematology 4:2, 185-197
CrossRef104
Lasse Wegener Lund, Kjeld Schmiegelow, Catherine Rechnitzer, Christoffer Johansen. (2011) A systematic review of studies on psychosocial late effects of childhood cancer: Structures of society and methodological pitfalls may challenge the conclusions. Pediatric Blood & Cancer 56:4, 532-543
CrossRef105
E. Woodward, M. Jessop, A. Glaser, D. Stark. (2011) Late effects in survivors of teenage and young adult cancer: does age matter?. Annals of Oncology
CrossRef106
Michele Montgomery, Sujuan Huang, Cheryl L. Cox, Wendy M. Leisenring, Kevin C. Oeffinger, Melissa M. Hudson, Jill Ginsberg, Gregory T. Armstrong, Leslie L. Robison, Kirsten K. Ness. (2011) Physical therapy and chiropractic use among childhood cancer survivors with chronic disease: impact on health-related quality of life. Journal of Cancer Survivorship 5:1, 73-81
CrossRef107
Jeffrey S. Willey, Shane A. J. Lloyd, Gregory A. Nelson, Ted A. Bateman. (2011) Ionizing Radiation and Bone Loss: Space Exploration and Clinical Therapy Applications. Clinical Reviews in Bone and Mineral Metabolism 9:1, 54-62
CrossRef108
Betül A Hatipoglu, Laurence Kennedy. (2011) Postradiation therapy hypopituitarism. Expert Review of Endocrinology & Metabolism 6:2, 187-194
CrossRef109
Sameer K. Nath, Ruben Carmona, Brent S. Rose, Daniel R. Simpson, Michelle Russell, Joshua D. Lawson, Arno J. Mundt, Kevin T. Murphy. (2011) Observed magnetic resonance imaging changes in pediatric patients treated with stereotactic radiosurgery for intracranial tumors. Child's Nervous System 27:3, 399-406
CrossRef110
Robert Olson, Gabe Hung, Mary Anne Bobinski, Karen Goddard. (2011) Prospective evaluation of legal difficulties and quality of life in adult survivors of childhood cancer. Pediatric Blood & Cancer 56:3, 439-443
CrossRef111
Barry H. Trachtenberg, David C. Landy, Vivian I. Franco, Jacqueline M. Henkel, Elliot J. Pearson, Tracie L. Miller, Steven E. Lipshultz. (2011) Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer. Pediatric Cardiology 32:3, 342-353
CrossRef112
Jennifer Eng, Jonathan D. Fish. (2011) Insidious iron burden in pediatric patients with acute lymphoblastic leukemia. Pediatric Blood & Cancer 56:3, 368-371
CrossRef113
Diana C. M. Seitz, Daniela Hagmann, Tanja Besier, Ute Dieluweit, Klaus-Michael Debatin, Desiree Grabow, Peter Kaatsch, Gerhard Henrich, Lutz Goldbeck. (2011) Life satisfaction in adult survivors of cancer during adolescence: what contributes to the latter satisfaction with life?. Quality of Life Research 20:2, 225-236
CrossRef114
, H. Schmidberger. (2011) Strahlentherapie und Langzeittoxizität. Forum
CrossRef115
S. M. Castellino, A. M. Geiger, A. C. Mertens, W. M. Leisenring, J. A. Tooze, P. Goodman, M. Stovall, L. L. Robison, M. M. Hudson. (2011) Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 117:6, 1806-1816
CrossRef116
Rajaram Nagarajan, Anmmd Kamruzzaman, Kirsten K. Ness, Victoria G. Marchese, Charles Sklar, Ann Mertens, Yutaka Yasui, Leslie L. Robison, Neyssa Marina. (2011) Twenty years of follow-up of survivors of childhood osteosarcoma. Cancer 117:3, 625-634
CrossRef117
Branlyn Werba DeRosa, Anne E. Kazak, Kinjal Doshi, Lisa A. Schwartz, Jill Ginsberg, Jun J. Mao, Joseph Straton, Wendy Hobbie, Mary T. Rourke, Claire Carlson, Richard F. Ittenbach. (2011) Development and Validation of the Health Competence Beliefs Inventory in Young Adults With and Without a History of Childhood Cancer. Annals of Behavioral Medicine 41:1, 48-58
CrossRef118
Jill H. Simmons. (2011) Growth abnormalities in pediatric all survivors exposed to lower-dose cranial radiation therapy: The need for continued surveillance. Pediatric Blood & Cancer 56:2, 173-174
CrossRef119
Sebastiaan L Knijnenburg, Renée L Mulder, Antoinette YN Schouten-Van Meeteren, Jaap W Groothoff, Arend Bökenkamp, Leontien CM Kremer, Monique WM Jaspers, Sebastiaan L Knijnenburg. 2011. Renal late adverse effects after potentially nephrotoxic treatment for childhood cancer. .
CrossRef120
B. Yin, K. S. Yang-Iott, L. H. Chao, C. H. Bassing. (2011) Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma. Blood 117:1, 175-185
CrossRef121
Liisa S. Järvelä, Jukka Kemppainen, Harri Niinikoski, Jarna C. Hannukainen, Päivi M. Lähteenmäki, Jukka Kapanen, Mikko Arola, Olli J. Heinonen. (2011) Effects of a home-based exercise program on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia. Pediatric Blood & Cancern/a-n/a
CrossRef122
Celeste R. Phillips-Salimi, Karen Lommel, Michael A. Andrykowski. (2011) Physical and mental health status and health behaviors of childhood cancer survivors: Findings from the 2009 BRFSS survey. Pediatric Blood & Cancern/a-n/a
CrossRef123
Enrico De Caro, Attilio Smeraldi, Gianluca Trocchio, MariaGrazia Calevo, Guia Hanau, Giacomo Pongiglione. (2011) Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors. Pediatric Blood & Cancer 56:1, 122-126
CrossRef124
Liisa S. Järvelä, Saija Hurme, Irma E. Holopainen, Maria Leino, Anne-Mari Hatanpää, Hannu Mikola, Tarmo Kärki, Toivo T. Salmi, Päivi M. Lähteenmäki. (2011) Auditory event related potentials as tools to reveal cognitive late effects in childhood cancer patients. Clinical Neurophysiology 122:1, 62-72
CrossRef125
Maru Barrera, Tanya Teall, Ronald Barr, Mariana Silva, Mark Greenberg. (2011) Health related quality of life in adolescent and young adult survivors of lower extremity bone tumors. Pediatric Blood & Cancern/a-n/a
CrossRef126
Jennifer Cohen, Claire E. Wakefield, Catharine A. K. Fleming, Rebecca Gawthorne, Linda C. Tapsell, Richard J. Cohn. (2011) Dietary intake after treatment in child cancer survivors. Pediatric Blood & Cancern/a-n/a
CrossRef127
Tseng-Tien Huang, Kirsten K. Ness. (2011) Exercise Interventions in Children with Cancer: A Review. International Journal of Pediatrics 2011, 1-11
CrossRef128
Cornelia E. Rebholz, Claudia E. Kuehni, Marie-Pierre F. Strippoli, Corina S. Rueegg, Gisela Michel, Heinz Hengartner, Eva Bergstraesser, Nicolas X. von der Weid, . (2011) Alcohol consumption and binge drinking in young adult childhood cancer survivors. Pediatric Blood & Cancern/a-n/a
CrossRef129
Rachael E. Windsor, Sandra J. Strauss, Constantinos Kallis, Nicholas E. Wood, Jeremy S. Whelan. (2011) Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma. Cancern/a-n/a
CrossRef130
Susanna J.E. Veringa, Eline van Dulmen-den Broeder, Gertjan J.L. Kaspers, Margreet A. Veening. (2011) Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia. Pediatric Blood & Cancern/a-n/a
CrossRef131
Steven E. Lipshultz, William T. Shearer, Bruce Thompson, Kenneth C. Rich, Irene Cheng, E. John Orav, Sulekha Kumar, Ricardo H. Pignatelli, Louis I. Bezold, Philip LaRussa, Thomas J. Starc, Julie S. Glickstein, Sharon O'Brien, Ellen R. Cooper, James D. Wilkinson, Tracie L. Miller, Steven D. Colan. (2011) Cardiac Effects of Antiretroviral Therapy in HIV-Negative Infants Born to HIV-Positive Mothers. Journal of the American College of Cardiology 57:1, 76-85
CrossRef132
Reid Hayward, Chia-Ying Lien, Brock T. Jensen, David S. Hydock, Carole M. Schneider. (2011) Exercise training mitigates anthracycline-induced chronic cardiotoxicity in a juvenile rat model. Pediatric Blood & Cancern/a-n/a
CrossRef133
Sophie Fosså, Hanne Hamre. (2011) Barnekreft og fertilitet. Tidsskrift for Den norske legeforening 131:15, 1412-1412
CrossRef134
Joy M. Fulbright. (2011) Review of Cardiotoxicity in Pediatric Cancer Patients: During and after Therapy. Cardiology Research and Practice 2011, 1-9
CrossRef135
Pinki K. Prasad, Lisa B. Signorello, Debra L. Friedman, John D. Boice, Eero Pukkala. (2011) Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatric Blood & Cancern/a-n/a
CrossRef136
Janet S de Moor, Elaine Puleo, Jennifer S Ford, Mark Greenberg, David C Hodgson, Vida L Tyc, Jamie Ostroff, Lisa R Diller, Andrea Levy, Kim Sprunck-Harrild, Karen M Emmons. (2011) Disseminating a smoking cessation intervention to childhood and young adult cancer survivors: baseline characteristics and study design of the partnership for health-2 study. BMC Cancer 11:1, 165
CrossRef137
Vivian I. Franco, Jacqueline M. Henkel, Tracie L. Miller, Steven E. Lipshultz. (2011) Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines. Cardiology Research and Practice 2011, 1-13
CrossRef138
Dursun Alehan, Murat Şahin, Ali Varan, Işıl Yıldırım, Serhan Küpeli, Münevver Büyükpamukçu. (2011) Tissue doppler evaluation of systolic and diastolic cardiac functions in long-term survivors of hodgkin lymphoma. Pediatric Blood & Cancern/a-n/a
CrossRef139
Lorenzo Iughetti, Patrizia Bruzzi. (2011) Obesity and craniopharyngioma. Italian Journal of Pediatrics 37:1, 38
CrossRef140
Claudia E. Kuehni, Marie-Pierre F. Strippoli, Corina S. Rueegg, Cornelia E. Rebholz, Eva Bergstraesser, Michael Grotzer, Nicolas X. von der Weid, Gisela Michel, . (2011) Educational achievement in Swiss childhood cancer survivors compared with the general population. Cancern/a-n/a
CrossRef141
Beth A. Kurt, Vikki G. Nolan, Kirsten K. Ness, Joseph P. Neglia, Jean M. Tersak, Melissa M. Hudson, Gregory T. Armstrong, Raymond J. Hutchinson, Wendy M. Leisenring, Kevin C. Oeffinger, Leslie L. Robison, Mukta Arora. (2011) Hospitalization rates among survivors of childhood cancer in the childhood cancer survivor study cohort. Pediatric Blood & Cancern/a-n/a
CrossRef142
Philip Lanzkowsky. 2011. Evaluation, Investigations and Management of Late Effects of Childhood Cancer. , 921-951.
CrossRef143
Philip Lanzkowsky. 2011. Psychosocial Aspects of Cancer for Children and their Families. , 952-967.
CrossRef144
Maru Barrera, Tanya Teall, Ronald Barr, Mariana Silva, Mark Greenberg. (2010) Sexual function in adolescent and young adult survivors of lower extremity bone tumors. Pediatric Blood & Cancer 55:7, 1370-1376
CrossRef145
Gregory T. Armstrong, Marilyn Stovall, Leslie L. Robison. (2010) Long-Term Effects of Radiation Exposure among Adult Survivors of Childhood Cancer: Results from the Childhood Cancer Survivor Study. Radiation Research 174:6b, 840-850
CrossRef146
J Steven Leeder, John Lantos, Stephen P Spielberg. (2010) Conference Scene: Pediatric pharmacogenomics and personalized medicine. Pharmacogenomics 11:12, 1691-1702
CrossRef147
Liisa S. Järvelä, Harri Niinikoski, Päivi M. Lähteenmäki, Olli J. Heinonen, Jukka Kapanen, Mikko Arola, Jukka Kemppainen. (2010) Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia. Journal of Cancer Survivorship 4:4, 339-345
CrossRef148
Martin Schrappe. (2010) Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial. The Lancet 376:9757, 1968-1970
CrossRef149
W. M. FitzPatrick, N. G. Dervisis, B. E. Kitchell. (2010) Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient*. Veterinary and Comparative Oncology 8:4, 273-282
CrossRef150
Kristin Bingen, Mary Jo Kupst. (2010) Evaluation of a Survivorship Educational Program for Adolescent and Young Adult Survivors of Childhood Cancer. Journal of Cancer Education 25:4, 530-537
CrossRef151
Shyh-Shin Chiou, Ren-Chin Jang, Yu-Mei Liao, Pinchen Yang. (2010) Health-related quality of life and cognitive outcomes among child and adolescent survivors of leukemia. Supportive Care in Cancer 18:12, 1581-1587
CrossRef152
R Phillips, K Absolom, D Stark, A Glaser. (2010) A simple practical patient-reported clinic satisfaction measure for young adults. British Journal of Cancer 103:10, 1485-1488
CrossRef153
Julie Wolfson, Kathleen Ruccione, Gregory H. Reaman. (2010) Health Care Reform 2010. The Cancer Journal 16:6, 554-562
CrossRef154
K. A. Enright, M. K. Krzyzanowska. (2010) Control of cardiovascular risk factors among adult cancer survivors: a population-based survey. Cancer Causes & Control 21:11, 1867-1874
CrossRef155
Annelies M.C. Mavinkurve-Groothuis, Jacqueline Groot-Loonen, Karen A. Marcus, Louise Bellersen, Ton Feuth, Jos P.M. Bökkerink, Peter M. Hoogerbrugge, Chris de Korte, Livia Kapusta. (2010) Myocardial Strain and Strain Rate in Monitoring Subclinical Heart Failure in Asymptomatic Long-Term Survivors of Childhood Cancer. Ultrasound in Medicine & Biology 36:11, 1783-1791
CrossRef156
Mark L. Kayton, Mai He, Maureen F. Zakowski, Andre L. Moreira, Christopher Lau, Alexander J. Chou, Melinda Merchant, Pamela R. Merola, Leonard H. Wexler, Michael P. La Quaglia, William D. Travis, Marc Ladanyi. (2010) Primary Lung Adenocarcinomas in Children and Adolescents Treated for Pediatric Malignancies. Journal of Thoracic Oncology 5:11, 1764-1771
CrossRef157
Lorna Finnegan, Joan L. Shaver, Shannon N. Zenk, Diana J. Wilkie, Carol Estwing Ferrans. (2010) The Symptom Cluster Experience Profile Framework. Oncology Nursing Forum 37:6, E377-E386
CrossRef158
Anne C. Kirchhoff, Wendy Leisenring, Kevin R. Krull, Kirsten K. Ness, Debra L. Friedman, Gregory T. Armstrong, Marilyn Stovall, Elyse R. Park, Kevin C. Oeffinger, Melissa M. Hudson, Leslie L. Robison, Thomas Wickizer. (2010) Unemployment Among Adult Survivors of Childhood Cancer. Medical Care 48:11, 1015-1025
CrossRef159
C.-L. Sun, L. Francisco, T. Kawashima, W. Leisenring, L. L. Robison, K. S. Baker, D. J. Weisdorf, S. J. Forman, S. Bhatia. (2010) Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 116:17, 3129-3139
CrossRef160
Naoko Maeda, Keizo Horibe, Koji Kato, Seiji Kojima, Masahito Tsurusawa. (2010) Survey of childhood cancer survivors who stopped follow-up physician visits. Pediatrics International 52:5, 806-812
CrossRef161
Roderick Skinner. (2010) Nephrotoxicity of cancer treatment in children. Pediatric Health 4:5, 519-538
CrossRef162
Thomas W. Buford, Stephen D. Anton, Andrew R. Judge, Emanuele Marzetti, Stephanie E. Wohlgemuth, Christy S. Carter, Christiaan Leeuwenburgh, Marco Pahor, Todd M. Manini. (2010) Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Research Reviews 9:4, 369-383
CrossRef163
Anna Sällfors Holmqvist, Thomas Wiebe, Lars Hjorth, Anna Lindgren, Ingrid Øra, Christian Moëll. (2010) Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood. Pediatric Blood & Cancer 55:4, 698-707
CrossRef164
I. Brana, J. Tabernero. (2010) Cardiotoxicity. Annals of Oncology 21:Supplement 7, vii173-vii179
CrossRef165
Louise Talbot, Helen Spoudeas. 2010. Late Effects in Relation to Childhood Cancer. , 367-391.
CrossRef166
Irma W.E.M. van Dijk, Foppe Oldenburger, Mathilde C. Cardous-Ubbink, Maud M. Geenen, Richard C. Heinen, Jan de Kraker, Flora E. van Leeuwen, Helena J.H. van der Pal, Huib N. Caron, Caro C.E. Koning, Leontien C.M. Kremer. (2010) Evaluation of Late Adverse Events in Long-Term Wilms' Tumor Survivors. International Journal of Radiation Oncology*Biology*Physics 78:2, 370-378
CrossRef167
Steven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, Stephen E Sallan, Lewis B Silverman, Tracie L Miller, Elly V Barry, Barbara L Asselin, Uma Athale, Luis A Clavell, Eric Larsen, Albert Moghrabi, Yvan Samson, Bruno Michon, Marshall A Schorin, Harvey J Cohen, Donna S Neuberg, E John Orav, Steven D Colan. (2010) Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. The Lancet Oncology 11:10, 950-961
CrossRef168
Joseph L. Wiemels, Michelle Kang, Jeffrey S. Chang, Lily Zheng, Carina Kouyoumji, Luoping Zhang, Martyn T. Smith, Ghislaine Scelo, Catherine Metayer, Patricia Buffler, John K. Wiencke. (2010) Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia. Blood Cells, Molecules, and Diseases 45:3, 186-191
CrossRef169
Baker, David L., Schmidt, Mary L., Cohn, Susan L., Maris, John M., London, Wendy B., Buxton, Allen, Stram, Daniel, Castleberry, Robert P., Shimada, Hiroyuki, Sandler, Anthony, Shamberger, Robert C., Look, A. Thomas, Reynolds, C. Patrick, Seeger, Robert C., Matthay, Katherine K., . (2010) Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma. New England Journal of Medicine 363:14, 1313-1323
Full Text170
Sabela Paradela, Eduardo Fonseca, Salvador Pita-Fernández, Sara M. Kantrow, Abdul H. Diwan, Cynthia Herzog, Victor G. Prieto. (2010) Prognostic factors for melanoma in children and adolescents. Cancer 116:18, 4334-4344
CrossRef171
Kevin R. Krull, Sujuan Huang, James G. Gurney, James L. Klosky, Wendy Leisenring, Amanda Termuhlen, Kirsten K. Ness, Deo Kumar Srivastava, Ann Mertens, Marilyn Stovall, Leslie L. Robison, Melissa M. Hudson. (2010) Adolescent behavior and adult health status in childhood cancer survivors. Journal of Cancer Survivorship 4:3, 210-217
CrossRef172
Saro H. Armenian, Can-Lan Sun, Jennifer Berano Teh, Mukta Arora, K. Scott Baker, Liton Francisco, Stephen J. Forman, Smita Bhatia. (2010) Ethnic differences in chronic health conditions after hematopoietic cell transplantation. Cancer 116:17, 4152-4159
CrossRef173
Quinn S. Wells, Daniel J. Lenihan. (2010) Reversibility of Left Ventricular Dysfunction Resulting from Chemotherapy: Can This Be Expected?. Progress in Cardiovascular Diseases 53:2, 140-148
CrossRef174
Nicole M.E. Bradley, Maria F. Lorenzi, Zenaida Abanto, Sam Sheps, Anne Marie Broemeling, John J. Spinelli, Karen Goddard, Sheila Pritchard, Paul Rogers, Mary L. McBride. (2010) Hospitalisations 1998–2000 in a British Columbia population-based cohort of young cancer survivors: Report of the Childhood/Adolescent/Young Adult Cancer Survivors (CAYACS) Research Program. European Journal of Cancer 46:13, 2441-2448
CrossRef175
J. P. Ginsberg, P. Goodman, W. Leisenring, K. K. Ness, P. A. Meyers, S. L. Wolden, S. M. Smith, M. Stovall, S. Hammond, L. L. Robison, K. C. Oeffinger. (2010) Long-term Survivors of Childhood Ewing Sarcoma: Report From the Childhood Cancer Survivor Study. JNCI Journal of the National Cancer Institute 102:16, 1272-1283
CrossRef176
Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Rosenberg, Eric S., Cort, Alice M., Ebeling, Sally H.Peters, Christine C., Ng, Andrea K., Abramson, Jeremy S., Digumarthy, Subba R., Reingold, Jason S., Stone, James R., . (2010) Case 24-2010. New England Journal of Medicine 363:7, 664-675
Full Text177
L. B. Travis, C. Beard, J. M. Allan, A. A. Dahl, D. R. Feldman, J. Oldenburg, G. Daugaard, J. L. Kelly, M. E. Dolan, R. Hannigan, L. S. Constine, K. C. Oeffinger, P. Okunieff, G. Armstrong, D. Wiljer, R. C. Miller, J. A. Gietema, F. E. van Leeuwen, J. P. Williams, C. R. Nichols, L. H. Einhorn, S. D. Fossa. (2010) Testicular Cancer Survivorship: Research Strategies and Recommendations. JNCI Journal of the National Cancer Institute 102:15, 1114-1130
CrossRef178
Francis Mussai, Dario Campana, Deepa Bhojwani, Maryalice Stetler-Stevenson, Seth M. Steinberg, Alan S. Wayne, Ira Pastan. (2010) Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia. British Journal of Haematology 150:3, 352-358
CrossRef179
Emily Dowling, K. Robin Yabroff, Angela Mariotto, Timothy McNeel, Christopher Zeruto, Dennis Buckman. (2010) Burden of illness in adult survivors of childhood cancers. Cancer 116:15, 3712-3721
CrossRef180
Kay K. Sundberg, Eva Doukkali, Claudia Lampic, Lars E. Eriksson, Johan Arvidson, Lena Wettergren. (2010) Long-term survivors of childhood cancer report quality of life and health status in parity with a comparison group. Pediatric Blood & Cancer 55:2, 337-343
CrossRef181
Marika J. Harila, Jarmo Salo, Marjatta Lanning, Ilpo Vilkkumaa, Arja H. Harila-Saari. (2010) High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer 55:2, 331-336
CrossRef182
D. L. Friedman, J. Whitton, W. Leisenring, A. C. Mertens, S. Hammond, M. Stovall, S. S. Donaldson, A. T. Meadows, L. L. Robison, J. P. Neglia. (2010) Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study. JNCI Journal of the National Cancer Institute 102:14, 1083-1095
CrossRef183
Gregory T. Armstrong. (2010) Long-term survivors of childhood central nervous system malignancies: The experience of the Childhood Cancer Survivor Study. European Journal of Paediatric Neurology 14:4, 298-303
CrossRef184
Mark W. McDonald, Markus M. Fitzek. (2010) Proton Therapy. Current Problems in Cancer 34:4, 257-296
CrossRef185
Yasushi Ishida, Naoko Sakamoto, Kiyoko Kamibeppu, Naoko Kakee, Tsuyako Iwai, Shuichi Ozono, Naoko Maeda, Jun Okamura, Keiko Asami, Hiroko Inada, Misato Honda, Keizo Horibe. (2010) Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy. International Journal of Hematology 92:1, 95-104
CrossRef186
Roderick Skinner, Annie Parry, Lisa Price, Michael Cole, Alan W. Craft, Andrew D.J. Pearson. (2010) Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatric Blood & Cancer 54:7, 983-989
CrossRef187
Katri V. Typpo, Nancy J. Petersen, Laura A. Petersen, M. Michele Mariscalco. (2010) Children with Chronic Illness Return to Their Baseline Functional Status after Organ Dysfunction on the First Day of Admission in the Pediatric Intensive Care Unit. The Journal of Pediatrics 157:1, 108-113.e1
CrossRef188
Melinda R. Stolley, Jacqueline Restrepo, Lisa K. Sharp. (2010) Diet and Physical Activity in Childhood Cancer Survivors: A Review of the Literature. Annals of Behavioral Medicine 39:3, 232-249
CrossRef189
Yasushi Ishida, Misato Honda, Shuichi Ozono, Jun Okamura, Keiko Asami, Naoko Maeda, Naoko Sakamoto, Hiroko Inada, Tsuyako Iwai, Kiyoko Kamibeppu, Naoko Kakee, Keizo Horibe. (2010) Late effects and quality of life of childhood cancer survivors: Part 1. Impact of stem cell transplantation. International Journal of Hematology 91:5, 865-876
CrossRef190
Oanh N. L. Le, Francis Rodier, Francois Fontaine, Jean-Philippe Coppe, Judith Campisi, James DeGregori, Caroline Laverdière, Victor Kokta, Elie Haddad, Christian M. Beauséjour. (2010) Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status. Aging Cell 9:3, 398-409
CrossRef191
Yannick Landry, Oanh Lê, Kimberly A. Mace, Terry E. Restivo, Christian M. Beauséjour. (2010) Secretion of SDF-1α by bone marrow-derived stromal cells enhances skin wound healing of C57BL/6 mice exposed to ionizing radiation. Journal of Cellular and Molecular Medicine 14:6b, 1594-1604
CrossRef192
Samart Pakakasama, Gavivann Veerakul, Darin Sosothikul, Su-on Chainansamit, Vichai Laosombat, Pattra Thanarattanakorn, Rachata Lumkul, Surapon Wiangnon, Somporn Wangruangsathit, Nattee Narkbunnam, Somjai Kanjanapongkul. (2010) Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group. International Journal of Hematology 91:5, 850-854
CrossRef193
Shawna L. Palmer, Wilburn E. Reddick, John O. Glass, Robert Ogg, Zoltan Patay, Dana Wallace, Amar Gajjar. (2010) Regional White Matter Anisotropy and Reading Ability in Patients Treated for Pediatric Embryonal Tumors. Brain Imaging and Behavior 4:2, 132-140
CrossRef194
Pinki K. Prasad, Travis Bowles, Debra L. Friedman. (2010) Is there a role for a specialized follow-up clinic for survivors of pediatric cancer?. Cancer Treatment Reviews 36:4, 372-376
CrossRef195
GREGORY J. LATHAM, ROBERT S. GREENBERG. (2010) Anesthetic considerations for the pediatric oncology patient - Part 3: pain, cognitive dysfunction, and preoperative evaluation. Pediatric Anesthesia 20:6, 479-489
CrossRef196
Inga M. R. Jóhannsdóttir, Marianne J. Hjermstad, Torbjørn Moum, Finn Wesenberg, Lars Hjorth, Henrik Schrøder, Päivi Lähteenmäki, Gudmundur Jónmundsson, Jon H. Loge. (2010) Social outcomes in young adult survivors of low incidence childhood cancers. Journal of Cancer Survivorship 4:2, 110-118
CrossRef197
Shuichi Ozono, Toshinari Saeki, Tomoyuki Mantani, Akiko Ogata, Hitoshi Okamura, Shin-ichiro Nakagawa, Koichiro Ueda, Hiroko Inada, Shigeto Yamawaki. (2010) Psychological distress related to patterns of family functioning among Japanese childhood cancer survivors and their parents. Psycho-Oncology 19:5, 545-552
CrossRef198
Pierantonio Menna, Emanuela Salvatorelli, Carlo Salsano, Luca Gianni, Giorgio Minotti. 2010. Cardiovascular Toxicity of Antitumor Drugs: Translating Molecular Mechanisms into Clinical Facts. , 223-256.
CrossRef199
Rebecca Scully, Steven E. Lipshultz. 2010. Cardiovascular Toxicity of Antitumor Drugs: Dimensions of the Problem in Children. , 97-126.
CrossRef200
Naomi Taylor, Kate Absolom, Gisela Michel, Tanya Urquhart, Mary Gerrard, Anna Jenkins, Vicki Lee, Ajay Vora, Christine Eiser. (2010) Comparison of self-reported late effects with medical records among survivors of childhood cancer. European Journal of Cancer 46:6, 1069-1078
CrossRef201
Marjolein van Waas, Sebastian J. Neggers, Aart-Jan van der Lelij, Rob Pieters, Marry M. van den Heuvel-Eibrink. (2010) The Metabolic Syndrome in Adult Survivors of Childhood Cancer, a Review. Journal of Pediatric Hematology/Oncology 32:3, 171-179
CrossRef202
GREGORY J. LATHAM, ROBERT S. GREENBERG. (2010) Anesthetic considerations for the pediatric oncology patient - part 1: a review of antitumor therapy. Pediatric Anesthesia 20:4, 295-304
CrossRef203
Adalet Meral Gunes, Erkan Can, Halil Saglam, Yeşim Özarda İlçöl, Birol Baytan. (2010) Assessment of Bone Mineral Density and Risk Factors in Children Completing Treatment for Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 32:3, e102-e107
CrossRef204
Gert R Dohle. (2010) Male infertility in cancer patients: Review of the literature. International Journal of Urology 17:4, 327-331
CrossRef205
M.C. Cardous-Ubbink, M.M. Geenen, K.J. Schade, R.C. Heinen, H.N. Caron, L.C.M. Kremer, F.E. Van Leeuwen. (2010) Hypertension in long-term survivors of childhood cancer: A nested case-control study. European Journal of Cancer 46:4, 782-790
CrossRef206
Krister K. Boman, Frank Lindblad, Anders Hjern. (2010) Long-term outcomes of childhood cancer survivors in Sweden: A population-based study of education, employment, and income. Cancer 116:5, 1385-1391
CrossRef207
Jay L. Grosfeld. (2010) William H. Harridge Memorial Lecture: “Progress and its unintended consequences”. The American Journal of Surgery 199:3, 284-288
CrossRef208
Meagan Lansdale, Sharon Castellino, Neyssa Marina, Pamela Goodman, Melissa M. Hudson, Ann C. Mertens, Stephanie M. Smith, Wendy Leisenring, Leslie L. Robison, Kevin C. Oeffinger. (2010) Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors. Cancer 116:4, 974-982
CrossRef209
Emanuel Raschi, Valentina Vasina, Maria Grazia Ursino, Giuseppe Boriani, Andrea Martoni, Fabrizio De Ponti. (2010) Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Pharmacology & Therapeutics 125:2, 196-218
CrossRef210
Kevin C. Oeffinger, Paul C. Nathan, Leontien C.M. Kremer. (2010) Challenges After Curative Treatment for Childhood Cancer and Long-Term Follow up of Survivors. Hematology/Oncology Clinics of North America 24:1, 129-149
CrossRef211
Esther C de Haas, Sjoukje F Oosting, Joop D Lefrandt, Bruce HR Wolffenbuttel, Dirk Th Sleijfer, Jourik A Gietema. (2010) The metabolic syndrome in cancer survivors. The Lancet Oncology 11:2, 193-203
CrossRef212
Alan S Wayne, Christian M Capitini, Crystal L Mackall. (2010) Immunotherapy of childhood cancer: from biologic understanding to clinical application. Current Opinion in Pediatrics 22:1, 2-11
CrossRef213
Melissa M Hudson. (2010) Pediatric cancer survivorship: is our work nearly done or just beginning?. Pediatric Health 4:1, 5-7
CrossRef214
Renée L Mulder, Elvira C van Dalen, Dorine Bresters, Yoon Loke, Edith Leclercq, Aleida Postma, Piet N Post, Bart GP Koot, Huib N Caron, Leontien CM Kremer, Renée L Mulder. 2010. Hepatic late adverse effects after treatment for childhood cancer. .
CrossRef215
Lisa B Kenney, Cheryl Medeiros Nancarrow, Julie Najita, Lynda M. Vrooman, Monica Rothwell, Christopher Recklitis, Frederick P. Li, Lisa Diller. (2010) Health status of the oldest adult survivors of cancer during childhood. Cancer 116:2, 497-505
CrossRef216
Karen Wasilewski-Masker, Ann C. Mertens, Briana Patterson, Lillian R. Meacham. (2010) Severity of health conditions identified in a pediatric cancer survivor program. Pediatric Blood & Cancern/a-n/a
CrossRef217
Taghrid Asfar, Robert C. Klesges, Stacy D. Sanford, Deborah Sherrill-Mittleman, Leslie L. Robison, Melissa M. Hudson, Grant Somes, James M. Boyett, Harry Lando. (2010) Trial design: The St. Jude Children's Research Hospital Cancer Survivors Tobacco Quit Line study. Contemporary Clinical Trials 31:1, 82-91
CrossRef218
Manabu Minami, Shigemi Matsumoto, Hisanori Horiuchi. (2010) Cardiovascular Side-Effects of Modern Cancer Therapy. Circulation Journal 74:9, 1779-1786
CrossRef219
Kirsten K. Ness, Chenghong Li, Pauline A. Mitby, Gretchen A. Radloff, Ann C. Mertens, Stella M. Davies, Sue Hammond, Gregory T. Armstrong, Leslie L. Robison. (2010) Characteristics of responders to a request for a buccal cell specimen among survivors of childhood cancer and their siblings. Pediatric Blood & Cancern/a-n/a
CrossRef220
Kimberly F. Whelan, Kayla Stratton, Toana Kawashima, John W. Waterbor, Robert P. Castleberry, Marilyn Stovall, Charles A. Sklar, Roger J. Packer, Pauline Mitby, Candice L. Aitken, Julie Blatt, Leslie L. Robison, Ann C. Mertens. (2010) Ocular late effects in childhood and adolescent cancer survivors: A report from the childhood cancer survivor study. Pediatric Blood & Cancer 54:1, 103-109
CrossRef221
Thad T. Ghim. (2010) Time to establish multidisciplinary childhood cancer survivorship programs in Korea. The Korean Journal of Hematology 45:2, 84
CrossRef222
D Bresters, I C M van Gils, W J W Kollen, L M Ball, W Oostdijk, J G van der Bom, R M Egeler. (2010) High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplantation 45:1, 79-85
CrossRef223
A. Lindsay Frazier, Robert C. Shamberger, Tara O. Henderson, Lisa Diller. (2010) Decision analysis to compare treatment strategies for Stage I/favorable histology Wilms tumor. Pediatric Blood & Cancern/a-n/a
CrossRef224
Jeffrey S. Willey, Eric W. Livingston, Michael E. Robbins, J. Daniel Bourland, Leidamarie Tirado-Lee, Hope Smith-Sielicki, Ted A. Bateman. (2010) Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations. Bone 46:1, 101-111
CrossRef225
David Buchbinder, Jacqueline Casillas, Kevin R. Krull, Pam Goodman, Wendy Leisenring, Christopher Recklitis, Melissa A. Alderfer, Leslie L. Robison, Gregory T. Armstrong, Alicia Kunin-Batson, Margaret Stuber, Lonnie K. Zeltzer. (2010) Psychological outcomes of siblings of cancer survivors: a report from the Childhood Cancer Survivor Study. Psycho-Oncologyn/a-n/a
CrossRef226
Kris Ann P. Schultz, Lu Chen, Zhengjia Chen, Lonnie K. Zeltzer, H. Stacy Nicholson, Joseph P. Neglia. (2010) Health and risk behaviors in survivors of childhood acute myeloid leukemia: A report from the Children's Oncology Group. Pediatric Blood & Cancern/a-n/a
CrossRef227
Daniel C. Bowers, Soumya Adhikari, Yasmin M. El-Khashab, Lynn Gargan, Kevin C. Oeffinger. (2009) Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors. Pediatric Blood & Cancer 53:7, 1295-1301
CrossRef228
Jonathan D. Fish, Jill P. Ginsberg. (2009) Health insurance for survivors of childhood cancer: A pre-existing problem. Pediatric Blood & Cancer 53:6, 928-930
CrossRef229
Kevin C. Oeffinger, Melissa M. Hudson, Wendy Landier. (2009) Survivorship: Childhood Cancer Survivors. Primary Care: Clinics in Office Practice 36:4, 743-780
CrossRef230
Michelle Kolb. (2009) Life After Pediatric Cancer. Clinical Journal of Oncology Nursing 13:6, E30-E40
CrossRef231
Patricia A. Ganz. (2009) Survivorship: Adult Cancer Survivors. Primary Care: Clinics in Office Practice 36:4, 721-741
CrossRef232
Susan Hong, Larissa Nekhlyudov, Aarati Didwania, Olufunmilayo Olopade, Pamela Ganschow. (2009) Cancer Survivorship Care: Exploring the Role of the General Internist. Journal of General Internal Medicine 24:S2, 495-500
CrossRef233
Saro H. Armenian, Smita Bhatia. (2009) Chronic Health Conditions in Childhood Cancer Survivors: Is it All Treatment-Related—or Do Genetics Play a Role?. Journal of General Internal Medicine 24:S2, 395-400
CrossRef234
Gill Levitt, Antoinette Anazodo, Michael Burch, Kathryn Bunch. (2009) Cardiac or cardiopulmonary transplantation in childhood cancer survivors: An increasing need?. European Journal of Cancer 45:17, 3027-3034
CrossRef235
Paul C. Nathan, Karen Wasilewski-Masker, Laura A. Janzen. (2009) Long-term Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America 23:5, 1065-1082
CrossRef236
Melinda S. Merchant. (2009) Long-term impact of cancer care on activities of daily living: Are we causing our sarcoma survivors to grow up too quickly?. Pediatric Blood & Cancer 53:4, 531-532
CrossRef237
Kathleen A. Meeske, Stuart E. Siegel, Vicente Gilsanz, Leslie Bernstein, Mary B. Nelson, Richard Sposto, Fred A. Weaver, Robert S. Lavey, M.P.H. Wendy J. Mack, Marvin D. Nelson. (2009) Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatric Blood & Cancer 53:4, 615-621
CrossRef238
Rebecca Parks, Elizabeth K. Rasch, Patrick J. Mansky, Frances Oakley. (2009) Differences in activities of daily living performance between long-term pediatric sarcoma survivors and a matched comparison group on standardized testing. Pediatric Blood & Cancer 53:4, 622-628
CrossRef239
Kevin C Oeffinger, Smita Bhatia. (2009) Second primary cancers in survivors of childhood cancer. The Lancet 374:9700, 1484-1485
CrossRef240
Melinda R. Stolley, Lisa K. Sharp, Claudia Arroyo, Cherese Ruffin, Jacqueline Restrepo, Richard Campbell. (2009) Design and recruitment of the Chicago Healthy Living Study. Cancer 115:S18, 4385-4396
CrossRef241
Karen E. Kinahan, Mona Gandhi, Mario E. Lacouture, Robert Eilers, Anand Haryani, Aarati Didwania, Lisa K. Sharp. (2009) Dermatologic issues in adult survivors of childhood cancer. Journal of Cancer Survivorship 3:3, 158-163
CrossRef242
K.K. Boman, E. Hovén, M. Anclair, B. Lannering, G. Gustafsson. (2009) Health and persistent functional late effects in adult survivors of childhood CNS tumours: A population-based cohort study. European Journal of Cancer 45:14, 2552-2561
CrossRef243
E. Brannon Morris, Chenghong Li, Raja B. Khan, Robert A. Sanford, Frederick Boop, Renee Pinlac, Xiaoping Xiong, Thomas E. Merchant. (2009) Evolution of neurological impairment in pediatric infratentorial ependymoma patients. Journal of Neuro-Oncology 94:3, 391-398
CrossRef244
I. G. M. Pas-van Voskuilen, J. S. J. Veerkamp, J. E. Raber-Durlacher, D. Bresters, A. J. Wijk, A. Barasch, S. McNeal, R. A. Th. Gortzak. (2009) Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Supportive Care in Cancer 17:9, 1169-1175
CrossRef245
Courtney D. Fitzhugh, Barbara Wise, Kristin Baird, Maria Tsokos, Lee Helman, Crystal Mackall, Sharon A. Savage, Katherine E. Warren. (2009) Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatric Blood & Cancer 53:3, 496-498
CrossRef246
C. Laverdiere, Q. Liu, Y. Yasui, P. C. Nathan, J. G. Gurney, M. Stovall, L. R. Diller, N.-K. Cheung, S. Wolden, L. L. Robison, C. A. Sklar. (2009) Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study. JNCI Journal of the National Cancer Institute 101:16, 1131-1140
CrossRef247
D M Greenfield, K Absolom, C Eiser, S J Walters, G Michel, B W Hancock, J A Snowden, R E Coleman. (2009) Follow-up care for cancer survivors: the views of clinicians. British Journal of Cancer 101:4, 568-574
CrossRef248
Normann Willich, Iris Ernst, Hildegard Pape, Christian Rübe, Beate Timmermann, Branka Asadpour, Rolf-Dieter Kortmann, Tobias Bölling. (2009) Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence: From Retrospective Case Reports to a Prospective, Multicentric and Transnational Approach. Strahlentherapie und Onkologie 185:S2, 3-4
CrossRef249
Robert J. Johnston, W. Hamish B. Wallace. (2009) Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer. Pediatric Blood & Cancer 53:2, 296-302
CrossRef250
Lorna Finnegan, Richard T. Campbell, Carol Estwing Ferrans, JoEllen Wilbur, Diana J. Wilkie, Joan Shaver. (2009) Symptom Cluster Experience Profiles in Adult Survivors of Childhood Cancers. Journal of Pain and Symptom Management 38:2, 258-269
CrossRef251
Helena K. Gleeson, Stephen M. Shalet. 2009. Evaluation and Management of Late Effects of Cancer Treatment. , 169-191.
CrossRef252
L.H. Aksnes, H.C.F. Bauer, A.A. Dahl, S.D. Fosså, L. Hjorth, N. Jebsen, H. Lernedal, K. Sundby Hall. (2009) Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: A Scandinavian sarcoma group study. Pediatric Blood & Cancer 53:1, 84-89
CrossRef253
Joseph P. Cravero. (2009) Caring for Adults With Pediatric Diseases. ASA Refresher Courses in Anesthesiology 37:1, 25-36
CrossRef254
Kay K. Sundberg, Claudia Lampic, Olle Björk, Johan Arvidson, Lena Wettergren. (2009) Positive and negative consequences of childhood cancer influencing the lives of young adults. European Journal of Oncology Nursing 13:3, 164-170
CrossRef255
H. MAURICE-STAM, F.J. OORT, B.F. LAST, P.P.T. BRONS, H.N. CARON, M.A. GROOTENHUIS. (2009) School-aged children after the end of successful treatment of non-central nervous system cancer: longitudinal assessment of health-related quality of life, anxiety and coping. European Journal of Cancer Care 18:4, 401-410
CrossRef256
G. T. Armstrong, Q. Liu, Y. Yasui, S. Huang, K. K. Ness, W. Leisenring, M. M. Hudson, S. S. Donaldson, A. A. King, M. Stovall, K. R. Krull, L. L. Robison, R. J. Packer. (2009) Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study. JNCI Journal of the National Cancer Institute 101:13, 946-958
CrossRef257
Alan S. Wayne. (2009) Application of immunotherapy in pediatric leukemia. Current Hematologic Malignancy Reports 4:3, 159-166
CrossRef258
Christine Berg, Peggy Neufeld, Jeanne Harvey, Amy Downes, Robert J. Hayashi. (2009) Late Effects of Childhood Cancer, Participation, and Quality of Life of Adolescents. OTJR: Occupation, Participation, Health 29:3, 116-124
CrossRef259
J. W. Han, S. Y. Kwon, S. C. Won, Y. J. Shin, J. H. Ko, C. J. Lyu. (2009) Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention. Annals of Oncology 20:7, 1170-1177
CrossRef260
Pui, Ching-Hon, Campana, Dario, Pei, Deqing, Bowman, W. Paul, Sandlund, John T., Kaste, Sue C., Ribeiro, Raul C., Rubnitz, Jeffrey E., Raimondi, Susana C., Onciu, Mihaela, Coustan-Smith, Elaine, Kun, Larry E., Jeha, Sima, Cheng, Cheng, Howard, Scott C., Simmons, Vickey, Bayles, Amy, Metzger, Monika L., Boyett, James M., Leung, Wing, Handgretinger, Rupert, Downing, James R., Evans, William E., Relling, Mary V., . (2009) Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation. New England Journal of Medicine 360:26, 2730-2741
Full Text261
Edward T.H. Yeh, Courtney L. Bickford. (2009) Cardiovascular Complications of Cancer Therapy. Journal of the American College of Cardiology 53:24, 2231-2247
CrossRef262
G. Michel, D.M. Greenfield, K. Absolom, R.J. Ross, H. Davies, C. Eiser. (2009) Follow-up care after childhood cancer: Survivors’ expectations and preferences for care. European Journal of Cancer 45:9, 1616-1623
CrossRef263
S. BROWN, A. BELGAUMI, A. KOFIDE, R. SABBAH, A. EZZAT, B. LITTLECHILD, M. SHOUKRI, R. BARR, A. LEVIN. (2009) Failure to attend appointments and loss to follow-up: a prospective study of patients with malignant lymphoma in Riyadh, Saudi Arabia. European Journal of Cancer Care 18:3, 313-317
CrossRef264
Smita Bhatia, Louis S. Constine. (2009) Late Morbidity After Successful Treatment of Children with Cancer. The Cancer Journal 15:3, 174-180
CrossRef265
J. Meitert, J. Peeters, M. Paulides, M. Metzler, J.D. Beck, H.G. Dörr, T. Langer. (2009) Nachsorge von Patienten mit Krebs im Kindes- und Jugendalter. Monatsschrift Kinderheilkunde 157:4, 329-338
CrossRef266
Garick Hill, Sharon Castellino, Derek Williams. (2009) Cardiac Myxoma After Treatment for Childhood Neuroblastoma. Pediatric Cardiology 30:3, 340-342
CrossRef267
E. Frey, A. Gessl, M. Riedel, A. Luger, H. Gadner. (2009) Nachsorge im Erwachsenenalter. Monatsschrift Kinderheilkunde 157:4, 339-345
CrossRef268
Margarett Shnorhavorian, Debra L. Friedman, Martin A. Koyle. (2009) Genitourinary long-term outcomes for childhood cancer survivors. Current Urology Reports 10:2, 134-137
CrossRef269
Kirsten K. Ness, Wendy Leisenring, Pam Goodman, Toana Kawashima, Ann C. Mertens, Kevin C. Oeffinger, Gregory T. Armstrong, Leslie L. Robison. (2009) Assessment of selection bias in clinic-based populations of childhood cancer survivors: A report from the childhood cancer survivor study. Pediatric Blood & Cancer 52:3, 379-386
CrossRef270
Suzanne A. Miles, Anthony D. Sandler. (2009) CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Advanced Drug Delivery Reviews 61:3, 275-282
CrossRef271
Charles L. Shapiro, Mary S. McCabe, Karen L. Syrjala, Debra Friedman, Linda A. Jacobs, Patricia A. Ganz, Lisa Diller, Marci Campell, Kathryn Orcena, Alfred C. Marcus. (2009) The LIVESTRONG Survivorship Center of Excellence Network. Journal of Cancer Survivorship 3:1, 4-11
CrossRef272
Vishnu Chintalgattu, Shalin S. Patel, Aarif Y. Khakoo. (2009) Cardiovascular Effects of Tyrosine Kinase Inhibitors Used for Gastrointestinal Stromal Tumors. Hematology/Oncology Clinics of North America 23:1, 97-107
CrossRef273
Edmund Y. Ko, Michael L. Ritchey. (2009) Current management of Wilms’ tumor in children. Journal of Pediatric Urology 5:1, 56-65
CrossRef274
Jessica Hochberg, Mitchell S. Cairo. (2009) Insight into the biology and treatment of pediatric lymphomas: Clues from international studies. Pediatric Blood & Cancer 52:2, 153-154
CrossRef275
Peter C. Adamson. (2009) Imaging in early phase childhood cancer trials. Pediatric Radiology 39:S1, 38-41
CrossRef276
Elske Sieswerda, Leontien C.M. Kremer, Suzanna Vidmar, Marie L. De Bruin, Elizabeth Smibert, Gunnar Sjöberg, Michael M.H. Cheung, Robert G. Weintraub. (2009) Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: A prospective follow-up study. Pediatric Blood & Cancern/a-n/a
CrossRef277
G.M.T. Guilcher, C. Fitzgerald, S. Pritchard. (2009) A questionnaire based review of long-term follow-up programs for survivors of childhood cancer in Canada. Pediatric Blood & Cancer 52:1, 113-115
CrossRef278
Hiroyuki Ishiguro, Yukiharu Yasuda, Hiromi Hyodo, Yuichiro Tomita, Takashi Koike, Tsuyoshi Shinagawa, Takashi Shimizu, Tsuyoshi Morimoto, Kinya Hattori, Masae Matsumoto, Hiroyasu Inoue, Hiromasa Yabe, Miharu Yabe, Osamu Shinohara, Shunichi Kato. (2009) Growth and Endocrine Function in Long-term Adult Survivors of Childhood Stem Cell Transplant. Clinical Pediatric Endocrinology 18:1, 1-14
CrossRef279
Jessica Hochberg, Ian M. Waxman, Kara M. Kelly, Erin Morris, Mitchell S. Cairo. (2009) Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. British Journal of Haematology 144:1, 24-40
CrossRef280
James L. Klosky, Darlene K. Cash, Joanna Buscemi, Shelly Lensing, Danette M. Garces-Webb, Wenyan Zhao, Sally Wiard, Melissa M. Hudson. (2008) Factors influencing long-term follow-up clinic attendance among survivors of childhood cancer. Journal of Cancer Survivorship 2:4, 225-232
CrossRef281
M. Steffens, V. Beauloye, B. Brichard, A. Robert, O. Alexopoulou, Ch. Vermylen, D. Maiter. (2008) Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clinical Endocrinology 69:5, 819-827
CrossRef282
Lena S. Sun, Guohua Li, Charles DiMaggio, Mary Byrne, Virginia Rauh, Jeanne Brooks-Gunn, Athina Kakavouli, Alastair Wood. (2008) Anesthesia and Neurodevelopment in Children. Anesthesiology 109:5, 757-761
CrossRef283
Raoul C. Reulen, Aliki J. Taylor, David L. Winter, Charles A. Stiller, Clare Frobisher, Emma R. Lancashire, Fabienne M. McClanahan, Elaine M. Sugden, Mike M. Hawkins, . (2008) Long-term population-based risks of breast cancer after childhood cancer. International Journal of Cancer 123:9, 2156-2163
CrossRef284
Emily S. Tonorezos, Kevin C. Oeffinger. (2008) Survivorship After Childhood, Adolescent, and Young Adult Cancer. The Cancer Journal 14:6, 388-395
CrossRef285
Kenneth D. Miller, Laura R. Triano. (2008) Medical Issues in Cancer Survivors—A Review. The Cancer Journal 14:6, 375-387
CrossRef286
A. C. Mertens, Q. Liu, J. P. Neglia, K. Wasilewski, W. Leisenring, G. T. Armstrong, L. L. Robison, Y. Yasui. (2008) Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study. JNCI Journal of the National Cancer Institute 100:19, 1368-1379
CrossRef287
R. Beck-Fruchter, A. Weiss, E. Shalev. (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Human Reproduction Update 14:6, 553-561
CrossRef288
A. S. Wayne, G. H. Reaman, L. J. Helman. (2008) Progress in the Curative Treatment of Childhood Hematologic Malignancies. JNCI Journal of the National Cancer Institute 100:18, 1271-1273
CrossRef289
Brigitte Royer-Pokora, Angela Weirich, Valerie Schumacher, Constanze Uschkereit, Manfred Beier, Ivo Leuschner, Norbert Graf, Frank Autschbach, Dominique Schneider, Melissa von Harrach. (2008) Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein β1 gene CTNNB1 for patients with Wilms tumors. Cancer 113:5, 1080-1089
CrossRef290
Gerald M. Rosen. (2008) Sleep and Wakefulness in Children with Brain Tumors. Sleep Medicine Clinics 3:3, 455-467
CrossRef291
Karen E. Kinahan, Lisa K. Sharp, Paul Arntson, Kathleen Galvin, Lauren Grill, Aarati Didwania. (2008) Adult Survivors of Childhood Cancer and Their Parents. Journal of Pediatric Hematology/Oncology 30:9, 651-658
CrossRef292
Sandra Shimoda, John Horsman, William Furlong, Ronald Barr, Beatriz de Camargo. (2008) Disability and Health-related Quality of Life in Long-term Survivors of Cancer in Childhood in Brazil. Journal of Pediatric Hematology/Oncology 30:8, 563-570
CrossRef293
Kendra Carswell, Yue Chen, Rama C. Nair, Amanda K. Shaw, Kathy N. Speechley, Maru Barrera, Elizabeth Maunsell. (2008) Smoking and binge drinking among Canadian survivors of childhood and adolescent cancers: A comparative, population-based study. Pediatric Blood & Cancer 51:2, 280-287
CrossRef294
Brent Anderson, Douglas B Sawyer. (2008) Predicting and preventing the cardiotoxicity of cancer therapy. Expert Review of Cardiovascular Therapy 6:7, 1023-1033
CrossRef295
A Shah, C A Stiller, M G Kenward, T Vincent, T O B Eden, M P Coleman. (2008) Childhood leukaemia: long-term excess mortality and the proportion ‘cured’. British Journal of Cancer 99:1, 219-223
CrossRef296
Gerardo Quezada, Lisa Kopp, Elihu Estey, Robert J. Wells. (2008) All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia. Pediatric Blood & Cancer 51:1, 133-135
CrossRef297
E. Anne Lown, Robert Goldsby, Ann C. Mertens, Thomas Greenfield, Jason Bond, John Whitton, Rachael Korcha, Leslie L. Robison, Lonnie K. Zeltzer. (2008) Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers. Addiction 103:7, 1139-1148
CrossRef298
J. Wiemels. (2008) Chromosomal Translocations in Childhood Leukemia: Natural History, Mechanisms, and Epidemiology. JNCI Monographs 2008:39, 87-90
CrossRef299
R. Mody, S. Li, D. C. Dover, S. Sallan, W. Leisenring, K. C. Oeffinger, Y. Yasui, L. L. Robison, J. P. Neglia. (2008) Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 111:12, 5515-5523
CrossRef300
Maris, John M., Mosse, Yael P., Bradfield, Jonathan P., Hou, Cuiping, Monni, Stefano, Scott, Richard H., Asgharzadeh, Shahab, Attiyeh, Edward F., Diskin, Sharon J., Laudenslager, Marci, Winter, Cynthia, Cole, Kristina A., Glessner, Joseph T., Kim, Cecilia, Frackelton, Edward C., Casalunovo, Tracy, Eckert, Andrew W., Capasso, Mario, Rappaport, Eric F., McConville, Carmel, London, Wendy B., Seeger, Robert C., Rahman, Nazneen, Devoto, Marcella, Grant, Struan F.A., Li, Hongzhe, Hakonarson, Hakon, . (2008) Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma. New England Journal of Medicine 358:24, 2585-2593
Full Text301
Kevin D. Stein, Karen L. Syrjala, Michael A. Andrykowski. (2008) Physical and psychological long-term and late effects of cancer. Cancer 112:S11, 2577-2592
CrossRef302
Daniel A. Mulrooney, Douglas C. Dover, Suwen Li, Yutaka Yasui, Kirsten K. Ness, Ann C. Mertens, Joseph P. Neglia, Charles A. Sklar, Leslie L. Robison, Stella M. Davies, . (2008) Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia. Cancer 112:9, 2071-2079
CrossRef303
Melissa M. Hudson, Catherine Patte. (2008) Education and health promotion in adolescent and young adult cancer survivors. Pediatric Blood & Cancer 50:S5, 1105-1108
CrossRef304
Heleen Maurice-Stam, Frans J. Oort, Bob F. Last, Paul P.T. Brons, Huib N. Caron, Martha A. Grootenhuis. (2008) Longitudinal assessment of health-related quality of life in preschool children with non-CNS cancer after the end of successful treatment. Pediatric Blood & Cancer 50:5, 1047-1051
CrossRef305
Gabriele Calaminus, Ronald Barr. (2008) Economic evaluation and health-related quality of life. Pediatric Blood & Cancer 50:S5, 1112-1115
CrossRef306
Julia H. Rowland, Keith M. Bellizzi. (2008) Cancer Survivors and Survivorship Research: A Reflection on Today's Successes and Tomorrow's Challenges. Hematology/Oncology Clinics of North America 22:2, 181-200
CrossRef307
Natalya Bublik, Jorge A. Alvarez, Steven E. Lipshultz. (2008) Pediatric cardiomyopathy as a chronic disease: A perspective on comprehensive care programs. Progress in Pediatric Cardiology 25:1, 103-111
CrossRef308
N Chen, K Aleksa, C Woodland, M Rieder, G Koren. (2008) N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. British Journal of Pharmacology 153:7, 1364-1372
CrossRef309
Melissa M. Hudson. (2008) Survivors of Childhood Cancer: Coming of Age. Hematology/Oncology Clinics of North America 22:2, 211-231
CrossRef310
Ria Blaauwbroek, Wemke Tuinier, Betty Meyboom-de Jong, Willem A Kamps, Aleida Postma. (2008) Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. The Lancet Oncology 9:3, 232-238
CrossRef311
Sophie D. Fosså, Rena Vassilopoulou-Sellin, Alv A. Dahl. (2008) Long term physical sequelae after adult-onset cancer. Journal of Cancer Survivorship 2:1, 3-11
CrossRef312
Kevin C Oeffinger. (2008) Shared care of adult survivors of childhood cancers. The Lancet Oncology 9:3, 191-193
CrossRef313
Sandra Brennan, Lucy E. Hann, Joachim Yahalom, Kevin C. Oeffinger, Jürgen Rademaker. (2008) Imaging of Late Complications from Mantle Field Radiation in Lymphoma Patients. Radiologic Clinics of North America 46:2, 419-430
CrossRef314
Joseph R. Carver, Andrea Ng, Anna T. Meadows, David J. Vaughn. (2008) Cardiovascular Late Effects and the Ongoing Care of Adult Cancer Survivors. Disease Management 11:1, 1-6
CrossRef315
Kevin C. Oeffinger. (2008) Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease?. Pediatric Blood & Cancer 50:S2, 462-467
CrossRef316
Paolo Paolucci, Kathy Pritchard Jones, Maria del Carmen Cano Garcinuno, Mariana Catapano, Achille Iolascon, Adriana Ceci. (2008) Challenges in prescribing drugs for children with cancer. The Lancet Oncology 9:2, 176-183
CrossRef317
Daniel A. Mulrooney, Joseph P. Neglia, Melissa M. Hudson. (2008) Caring for Adult Survivors of Childhood Cancer. Current Treatment Options in Oncology 9:1, 51-66
CrossRef318
Kevin C. Oeffinger, Paul C. Nathan, Leontien C.M. Kremer. (2008) Challenges After Curative Treatment for Childhood Cancer and Long-Term Follow up of Survivors. Pediatric Clinics of North America 55:1, 251-273
CrossRef319
Raul Ribeiro, Ching-Hon Pui. (2008) Treatment of acute lymphoblastic leukemia in low- and middle-income countries: Challenges and opportunities. Leukemia & Lymphoma 49:3, 373-376
CrossRef320
Miho Maeda. (2008) Late Effects of Childhood Cancer: Life-threatening Issues. Journal of Nippon Medical School 75:6, 320-324
CrossRef321
Kirsten K. Ness, James G. Gurney, Lonnie K. Zeltzer, Wendy Leisenring, Daniel A. Mulrooney, Paul C. Nathan, Leslie L. Robison, Ann C. Mertens. (2008) The Impact of Limitations in Physical, Executive, and Emotional Function on Health-Related Quality of Life Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Archives of Physical Medicine and Rehabilitation 89:1, 128-136
CrossRef322
L J N Cooper. (2008) Adoptive cellular immunotherapy for childhood malignancies. Bone Marrow Transplantation 41:2, 183-192
CrossRef323
G. Michel. (2008) Leucemia linfobl??stica aguda del ni??o y del adolescente: cl??nica y tratamiento. EMC - Pediatr??a 43:4, 1-11
CrossRef324
S. Varma. (2008) Childhood Leukemia Survivors At Risk for Harmful Obesity. AAP Grand Rounds 19:1, 5-5
CrossRef325
Jenny W.Y. Pang, Debra L. Friedman, John A. Whitton, Marilyn Stovall, Ann C. Mertens, Leslie L. Robison, Noel S. Weiss. (2008) Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatric Blood & Cancer 50:1, 104-110
CrossRef326
Sue C. Kaste, Jeffrey S. Dome, Paul S. Babyn, Norbert M. Graf, Paul Grundy, Jan Godzinski, Gill A. Levitt, Helen Jenkinson. (2008) Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatric Radiology 38:1, 2-17
CrossRef327
Marina Servitzoglou, Danai Papadatou, Ioannis Tsiantis, Helen Vasilatou-Kosmidis. (2008) Psychosocial functioning of young adolescent and adult survivors of childhood cancer. Supportive Care in Cancer 16:1, 29-36
CrossRef328
J.A. Stockman. (2008) Chronic Health Conditions in Adult Survivors of Childhood Cancer. Yearbook of Pediatrics 2008, 441-443
CrossRef329
Sonia Partap, Paul Graham Fisher. (2007) Update on new treatments and developments in childhood brain tumors. Current Opinion in Pediatrics 19:6, 670-674
CrossRef330
Leslie L. Robison, Melissa M. Hudson. (2007) Medical surveillance of long-term survivors of childhood cancer. European Journal of Cancer 43:18, 2629-2630
CrossRef331
Ria Blaauwbroek, Nynke Zwart, Martijn Bouma, Betty Meyboom-de Jong, Willem A. Kamps, Aleida Postma. (2007) The willingness of general practitioners to be involved in the follow-up of adult survivors of childhood cancer. Journal of Cancer Survivorship 1:4, 292-297
CrossRef332
Ya-Ling Lee, Sheila Judge Santacroce, Lois Sadler. (2007) Predictors of healthy behaviour in long-term survivors of childhood cancer. Journal of Clinical Nursing 16:11c, 285-295
CrossRef333
G Michel, P Bordigoni, M-C Simeoni, C Curtillet, S Hoxha, S Robitail, I Thuret, S Pall-Kondolff, H Chambost, D Orbicini, P Auquier. (2007) Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation. Bone Marrow Transplantation 40:9, 897-904
CrossRef334
Susan B. Nunez, Daniel A. Mulrooney, Caroline Laverdiere, Melissa M. Hudson. (2007) Risk-based health monitoring of childhood cancer survivors: A report from the children’s oncology group. Current Oncology Reports 9:6, 440-452
CrossRef335
K. L. Syrjala, B. F. Kurland, J. R. Abrams, J. E. Sanders, J. R. Heiman. (2007) Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood 111:3, 989-996
CrossRef336
R. M. Vigeveno, L. C. M. Kremer, P. B. A. Smits. (2007) Werkeloosheid als laat gevolg van kinderkanker. Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde 15:10, 488-489
CrossRef337
Deborah B. Crom, Shelly Y. Lensing, Shesh N. Rai, Mark A. Snider, Darlene K. Cash, Melissa M. Hudson. (2007) Marriage, employment, and health insurance in adult survivors of childhood cancer. Journal of Cancer Survivorship 1:3, 237-245
CrossRef338
Michael Weintraub, Shoshana Revel-Vilk, Mira Charit, Memet Aker, Jacob P??er. (2007) Secondary Acute Myeloid Leukemia After Etoposide Therapy for Retinoblastoma. Journal of Pediatric Hematology/Oncology 29:9, 646-648
CrossRef339
Gerald M. Rosen. (2007) Sleep in Children Who Have Cancer. Sleep Medicine Clinics 2:3, 491-500
CrossRef340
Christopher Lethaby, John Wiernikowski, Alessandra Sala, Marissa Naronha, Colin Webber, Ronald D. Barr. (2007) Bisphosphonate Therapy for Reduced Bone Mineral Density During Treatment of Acute Lymphoblastic Leukemia in Childhood and Adolescence. Journal of Pediatric Hematology/Oncology 29:9, 613-616
CrossRef341
Giulio J. D??Angio. (2007) Perspective. Journal of Pediatric Hematology/Oncology 29:9, 595-597
CrossRef342
Krister K Boman. (2007) Assessing psychological and health-related quality of life (HRQL) late effects after childhood cancer. Acta Paediatrica 96:9, 1265-1268
CrossRef343
Tara E. O’Leary, Lisa Diller, Christopher J. Recklitis. (2007) The effects of response bias on self-reported quality of life among childhood cancer survivors. Quality of Life Research 16:7, 1211-1220
CrossRef344
Andrew M. Donson, Nicole S. Erwin, B. K. Kleinschmidt-DeMasters, Jennifer R. Madden, Steven O. Addo-Yobo, Nicholas K. Foreman. (2007) Unique Molecular Characteristics of Radiation-Induced Glioblastoma. Journal of Neuropathology and Experimental Neurology 66:8, 740-749
CrossRef345
Meilan M Rutter, Susan R Rose. (2007) Long-term endocrine sequelae of childhood cancer. Current Opinion in Pediatrics 19:4, 480-487
CrossRef346
Karen Driscoll, Michael Isakoff, Fernando Ferrer. (2007) Update on pediatric genitourinary oncology. Current Opinion in Urology 17:4, 281-286
CrossRef347
A.-G. Chaume, C. Berger, P. Cathébras. (2007) Séquelles et qualité de vie chez de jeunes adultes survivants de cancers pédiatriques. La Revue de Médecine Interne 28:7, 450-457
CrossRef348
Rebecca E. Scully, Steven E. Lipshultz. (2007) Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovascular Toxicology 7:2, 122-128
CrossRef349
Herwig Lackner, Andrea Moser, Petra Sovinz, Martin Benesch, Wolfgang Schwinger, Christian Urban. (2007) Langzeitbetreuung junger Erwachsener nach Krebserkrankung im Kindesalter – Wohin führt der Weg?. Wiener klinische Wochenschrift 119:11-12, 361-364
CrossRef350
Elly Barry, Jorge A Alvarez, Rebecca E Scully, Tracie L Miller, Steven E Lipshultz. (2007) Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opinion on Pharmacotherapy 8:8, 1039-1058
CrossRef351
Thomas Force, Daniela S. Krause, Richard A. Van Etten. (2007) Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nature Reviews Cancer 7:5, 332-344
CrossRef352
Christine Eiser, Kate Absolom, Diana Greenfield, John Snowden, Robert Coleman, Barry Hancock, Helena Davies, . (2007) Follow-up care for young adult survivors of cancer: lessons from pediatrics. Journal of Cancer Survivorship: Research and Practice 1:1, 75-86
CrossRef353
Craig C. Earle. (2007) Long term care planning for cancer survivors: a health services research agenda. Journal of Cancer Survivorship: Research and Practice 1:1, 64-74
CrossRef354
E. Does, T. Gelder. (2007) Morbiditeit bij volwassenen, als kind behandeld voor kanker. Medisch-Farmaceutische Mededelingen 45:4, 126-127
CrossRef355
Sharon E. Oberfield. (2007) Childhood Cancer Cures: The Ongoing Consequences of Successful Treatments. The Journal of Pediatrics 150:4, 332-334
CrossRef356
(2007) Adult survivors of pediatric cancer at high risk of developing chronic health conditions. Nature Clinical Practice Oncology 4:3, 141-141
CrossRef357
J. D. Boice. (2007) An Affair of the Heart. JNCI Journal of the National Cancer Institute 99:3, 186-187
CrossRef358
Jorge A Alvarez, Rebecca E Scully, Tracie L Miller, F Daniel Armstrong, Louis S Constine, Debra L Friedman, Steven E Lipshultz. (2007) Long-term effects of treatments for childhood cancers. Current Opinion in Pediatrics 19:1, 23-31
CrossRef359
(2007) Survivors of Childhood Cancer. New England Journal of Medicine 356:2, 191-194
Full Text360
(2006) News In brief. Nature Medicine 12:11, 1226-1227
CrossRef361
Rosoff, Philip M., . (2006) The Two-Edged Sword of Curing Childhood Cancer. New England Journal of Medicine 355:15, 1522-1523
Full Text
- Letters
